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 Drug addiction is a chronic disease characterized by recurring episodes of 
abstinence and relapse. The mechanisms that underlie this pattern are yet to be 
elucidated. Recently, we reported that abstinent rats with a history of chronic food 
restriction show increased heroin seeking compared to sated controls. It is thought that 
food restriction may cause sensitization of drug seeking due to its stress-like properties, 
suggesting a critical role for corticotropin-releasing factor (CRF) and corticosterone, 
hormones involved in the stress response. Blocking corticosterone reduces food 
restriction-induced sensitization of locomotor activity in response to cocaine, while acute 
food-deprivation induced reinstatement of extinguished drug seeking is attenuated by 
CRF antagonism but not removal of corticosterone. The role of CRF and corticosterone 
in food restriction-induced augmentation of drug seeking remains unknown. Here, male 
Long-Evans rats were trained to self-administer heroin for 10 days in operant 
conditioning chambers. Following self-administration rats were subjected to 14 days of 
unrestricted (sated group) or a mildly restricted (FDR group) access to food, which 
maintained their body weight at ~75% of the sated rats’ body weight. On day 14, rats 
were administered a selective CRF1 receptor antagonist (R121919; 0.0, 20.0 mg/kg; IP), 
 iv 
non-selective CRF receptor antagonist (α-helical CRF; 0.0, 10.0, 25.0 μg/μl; ICV) or a 
glucocorticoid receptor antagonist (RU486; 0.0, 30.0 mg/kg; IP), and underwent a 1 h 
drug seeking test under extinction conditions. Rats in the FDR group showed a 
statistically significant increase in heroin seeking compared to the sated group. No 
statistically significant effects for treatment with R121919, α-helical CRF or RU486 were 
observed. These findings suggest that stress may not be a critical factor in our paradigm. 
In an exploratory study to identify brain sites involved in this effect rats were sacrificed 
post-test and the expression of the immediate early gene, c-fos, an indicator of neuronal 
activity, was measured using immunohistochemistry. Interestingly, a statistically 
significant decrease in Fos immunoreactivity in the nucleus accumbens shell was 
observed for the FDR compared to sated rats. Although stress may not be a critical factor 
in our effect, prolonged exposure to food restriction does cause alterations in reward-
related brain sites. The identification of specific neuron types affected in these regions 
should drive future studies.  
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in the animal care facility. Rats were matched according to body weight, active lever 
responding and drug infusions before separation into the FDR or Sated group. On day 14 
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Figure 3. The effect of exposure to prolonged food restriction (FDR) on heroin seeking 
in abstinent rats. Data shown are the mean (+SEM) active and inactive lever responding 
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Active lever responding was statistically significantly greater for the FDR group versus 
Sated controls. * p = .016. 
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FDR or sated conditions. No statistically significant results were observed across 
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FDR or sated conditions. No statistically significant results were observed across 
antagonist dose (0.0, 20.0 mg/kg) in the FDR (n’s: FDR-0.0 = 6, FDR-20.0 = 7)  or Sated 
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self-administration training and 14 days of abstinence under FDR or sated conditions. 
Active lever responding was statistically significantly greater for the FDR group versus 
Sated controls. * p < .001. 
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conditions, following heroin self-administration training and 14 days of abstinence under 
FDR or sated conditions. No statistically significant results were observed across 
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open arena following injections of α-Helical CRF (0.0, 25.0 μg/kg; ICV), in food 
restricted rats (n’s: 0.0 μg/kg = 4, 25.0 μg/kg = 3). * p = .038. 
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self-administration training and 16 days of abstinence under FDR or sated conditions. 
Active and inactive lever responding was statistically significantly greater for the FDR 
group versus Sated controls. * p = .008 & p = .019 respectively. 
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antagonist dose (0.0, 30.0 mg/kg) in the FDR (n’s: FDR-0.0 = 7, FDR-30.0 = 7) or Sated 
(n’s: Sated-0.0 = 8, Sated-30.0 = 5) groups. 
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day, in experiment 2. Test day consisted of one 1-h test session under extinction 
conditions, following heroin self-administration training and 16 days of abstinence under 
FDR or sated conditions. No statistically significant results were observed across 
antagonist dose (0.0, 30.0 mg/kg) in the FDR (n’s: FDR-0.0 = 7, FDR-30.0 = 7) or Sated 
(n’s: Sated-0.0 = 8, Sated-30.0 = 5) groups. 
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representative tissue slice from the food restricted (FDR) group (n = 11). B (lower panel): 
pictograph of representative tissue slice from the Sated group (n = 14). Following self-
administration training, on abstinence day 14, rats were immediately sacrificed following 









Figure 16. The effect of exposure to prolonged food restriction (FDR) on heroin seeking 
in abstinent rats. Data shown are the mean (+SEM) active and inactive lever responding 
on test day, for the FDR (n =11 ) and Sated groups (n = 14) for experiment 1. Test day 
consisted of one 1-h test session under extinction conditions, following heroin self-
administration training and 14 days of abstinence under FDR or sated conditions. Active 
lever responding was statistically significantly greater for the FDR group versus sated 
controls. * p < .001. 
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mean (+SEM) counts of Fos protein IR cells in the food restricted (FDR) and Sated 
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abstinence day 14, rats were immediately sacrificed following a 1 h test under extinction 
conditions, or at the same time a test would have occurred. *p < .014. 
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group, for the heroin-trained-tested, heroin-trained-no-test and drug-naive groups. On 
abstinence day 14, rats were immediately sacrificed following a 1 h test under extinction 
conditions, or at the same time a test would have occurred. 
 
Figure 19. Fos protein IR-labeling in the basolateral amygdala. Data shown are the mean 










the heroin-trained-tested, heroin-trained-no-test and drug-naive groups. On abstinence 
day 14, rats were immediately sacrificed following a 1 h test under extinction conditions, 
or at the same time a test would have occurred. 
 
Figure 20. Fos protein IR-labeling in the central extended amygdala. Data shown are the 
mean (+SEM) counts of Fos protein IR cells in the food restricted (FDR) and Sated 
group, for the heroin-trained-tested, heroin-trained-no-test and drug-naive groups. On 
abstinence day 14, rats were immediately sacrificed following a 1 h test under extinction 
conditions, or at the same time a test would have occurred. 
 
Figure 21. Fos protein IR-labeling in the prelimbic cortex. Data shown are the mean 
(+SEM) counts of Fos protein IR cells in the food restricted (FDR) and Sated group, for 
the heroin-trained-tested, heroin-trained-no-test and drug-naive groups. On abstinence 
day 14, rats were immediately sacrificed following a 1 h test under extinction conditions, 
or at the same time a test would have occurred. 
 
Figure 22. Fos protein IR-labeling in the infralimbic cortex. Data shown are the mean 
(+SEM) counts of Fos protein IR cells in the food restricted (FDR) and Sated group, for 
the heroin-trained-tested, heroin-trained-no-test and drug-naive groups. On abstinence 
day 14, rats were immediately sacrificed following a 1 h test under extinction conditions, 









Figure A1. Timeline of experimental procedure. The procedure consists of three phases: 
animals are first trained to self-administer a drug in the presence of a cue/tone complex 
(training phase), then moved to a different context and undergo a one day, drug washout 
period, followed by a prolonged period of food restriction (FDR) or unlimited access to 
food (abstinence phase) and finally returned to the self-administration environment for a 
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General Introduction 
  
 Drug addiction is a chronic disease characterized by recurring episodes of 
abstinence and relapse. Despite negative health, social, and psychological consequences 
of drug abuse, nearly 200,000 Canadians are dependent on illicit drugs, accruing costs of 
over eight billion dollars per year in medical care, crime-related damages and expenses, 
and the toll of addressing other social problems (Health Reports, 2004). These are 
significant but the perception of the “recreational”, non-therapeutic nature of drug-uses 
can have a negative impact on the progress of treatment efforts (McLellan, 2000). As a 
result, treatment for drug addiction remains widely ineffective. As many as 80% of 
abstinent drugs users return to active substance use within one year following treatment 
(Hser, Grella, Shen, & Anglin, 2000), providing further evidence that the treatment of 
drug addiction remains inadequate.  
Treatment of relapse typically involves acute, rescue pharmacological 
intervention and thus reflects a poor model of chronic disease management (White, 
Boyle, & Loveland, 2002). While relapse may occur shortly after drug cessation, it is not 
the presence of withdrawal symptoms that precipitates drug relapse. Instead, it is the 
subjective craving and the urge to seek out the drug (Robinson & Berridge, 1993; Wise & 
Bozarth, 1987). In fact, abstinent drug users often report an incubation period, whereby 
drug craving increases over time (Gawin & Kleber, 1986), contrary to the expectation 
that it will diminish as time passes. Thus, relapse may occur following many months or 
years of abstinence (Hser, Hoffman, Grella, & Anglin, 2001).  
It is believed that a neurobiological approach to drug addiction is critical to 
develop efficient research-directed treatments for addiction, particularly since drugs of 
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abuse have been shown to alter neural structures, functions, and brain chemistry. These 
alterations may affect the motivational and cognitive processes that are fundamental to 
relapse (Koob & Bloom, 1988). The persistent changes in brain chemistry may also 
increase vulnerability to triggers that induce relapse, such as re-exposure to drug-
associated cues and environments (Childress et al., 1993), to the drug itself (De Wit, 
1996), and to stressful situations (Sinha, 2001). 
 Drug users consistently report stress as a factor in subjective craving as well as in 
the initiation, maintenance and relapse of drug use (Brewer, Catalano, Haggerty, Gainey, 
& Fleming, 1998; Matheny & Weatherman, 1998; Sinha, 2001; 2008; Sinha & O'Malley, 
1999). The definition of “stress” has proven to be difficult, but for the purpose of our 
discussion, stress can be defined as the experience of negative emotions combined with 
predictable changes in physiology, biochemistry, behavior, and cognition (Baum, 1990). 
For stress to remain manageable, physiological systems operate to suppress unnecessary 
functions and activate those required for immediate survival (Kemeny, 2003). While 
adaptive upon exposure to short-term stressors, chronic over-activation can disrupt these 
systems and negatively alter reactions to stress (McEwen, 1998). Thus, although 
performance in demanding tasks is facilitated by mild, short-term stress, negative, 
uncontrollable, unpredictable and chronic stress renders such goal-oriented tasks 
unmanageable or overwhelming (Lazarus, 1999; Levine, 2005; Lovallo, 2005; McEwen, 
2002; Meaney, Brake, & Gratton, 2002; Selye, 1984). In addition, threat is experienced 
when the demands in a given situation are perceived to outweigh the resources available 
to that individual (Blascovich, 1996). It is this negative psychological or physiological 
stress that may trigger a return to drug use (Back et al., 2010; Sinha, 2001; 2008).  
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  A role for stress as a potential trigger for relapse to drugs has been identified both 
in retrospective studies involving interviews and questionnaires given to addicts, and in 
controlled laboratory studies. For example, studies by Kosten and colleagues (1983; 
1986) suggest that stress is associated with relapse, as opioid users reported experiencing 
a greater number of stressful life events when compared to healthy controls. A different 
approach involves the exposure of abstinent addicts to structured, individually adjusted 
scripts describing highly relevant stressful experiences in laboratory settings, resulting in 
increased subjective drug-craving (Sinha, Garcia, Paliwal, Kreek, & Rounsaville, 2006). 
 While a role for stress in drug abuse and relapse is clearly indicated, the 
mechanisms that underlie this effect have not been completely elucidated. Both clinical 
and pre-clinical studies have demonstrated that stress can activate reward-related brain 
regions, while drugs of abuse can activate stress-related brain regions (Bossert, Ghitza, 
Lu, Epstein, & Shaham, 2005; Koob, 2008; Sinha, 2008). These findings suggest a 
neurobiological link between stress and abused drugs (Sinha, 2001; 2007). One 
explanation, therefore, is that stress activates brain reward circuitry, resulting in an 
increased sensitivity to the reinforcing properties of abused drugs, leading to a greater 
motivation for drug seeking (Piazza & Le Moal, 1998; Sinha, 2009). Drug use can also 
cause the structural and chemical modification of neural pathways, producing an 
increasingly negative response to stress, and therefore further motivating drug seeking 
behavior (Sinha, 2001; 2005). 
 The aforementioned studies suggest a critical role for stress in driving drug use 
and consequently drug relapse in human subjects. However, the study of relapse in 
humans is difficult and fraught with ethical obstacles. To elucidate the underlying 
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neurobiological mechanisms involved in drug craving, motivational processes and 
relapse, the use of animal models is crucial.  
 One of the most frequently used models for drug relapse in recent years is the 
self-administration-based reinstatement procedure. Briefly, animals are trained to perform 
an operant response to self administer a drug. Successful drug administration is often 
paired with the presentation of discrete cues (e.g., light or tone). The drug seeking 
behavior is then extinguished by the removal of the drug while keeping all other 
conditions similar to training. The animals can then be exposed to any of the conditions 
known to trigger craving and relapse in humans (de Wit & Stewart, 1981; Shaham, 
Shalev, Lu, & de Wit, 2003). Accordingly, reintroduction to a previously drug-paired 
environmental context, exposure to discrete drug-associated cues or to a small dose of a 
previously administered drug (e.g. heroin, cocaine) and exposure to a stressor such as 
electrical footshock stress, have all been shown to successfully reinstate extinguished 
drug-seeking (Shalev, Grimm, & Shaham, 2002; Stewart, 2000). 
 Using the reinstatement procedure, significant advances in uncovering the 
neuronal circuitry underlying stress-induced reinstatement has been made. Reports from 
Shaham and colleagues (1997) strongly implicate stress-induced activation of the 
corticotropin-releasing factor (CRF) system in the reinstatement of drug seeking. CRF, 
which is synthesized and released by the hypothalamus and extra-hypothalamic brain 
regions, is a main component in the behavioral and physiological response to stress 
(DeSouza, 1995; Koob, Heinrichs, Menzaghi, Pich, & Britton, 1994; Turnbull & Rivier, 
1997). It was demonstrated that CRF receptor antagonism attenuates electrical footshock-
induced reinstatement of heroin seeking and cocaine seeking (Shaham et al., 1997). In 
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contrast, the removal or blockade of corticosterone, the product of stress-induced 
activation of the hypothalamus-pituitary-adrenal (HPA) axis, does not attenuate 
footshock-induced reinstatement, thus providing evidence that CRF may be acting on 
extra-hypothalamic targets rather than on the activation of the HPA axis (Shaham et al., 
1997).  
 A second major component in the central stress response is the activation of 
noradrenergic (NA) projections from the brain stem. The dorsal NAergic bundle projects 
from the locus coeruleus (LC), to cortical brain regions (Moore & Bloom, 1979), and is 
involved in the stress response (Tanaka et al., 1990). Shaham and colleagues (2000b), 
however, reported no effect of intra-LC infusions of the α-2 adrenoreceptor agonist 
clonidine on footshock-induced reinstatement of heroin seeking. Alternatively, the 
ventral NAergic bundle (VNAB) involves projections from the lateral tegmental nuclei, 
to brain regions such as the central extended amygdala (CeA) and nucleus accumbens 
(Aston-Jones, Delfs, Druhan, & Zhu, 1999; Fritschy & Grzanna, 1991; Moore & Bloom, 
1979). This pathway may play a more prominent role in stress-induced reinstatement of 
drug seeking , as 6-Hydroxydopamine lesions of the lateral tegmental area attenuated 
footshock-induced reinstatement (Shaham et al., 2000b).   
 The CRF and NAergic brain systems may interact to modulate footshock-induced 
reinstatement. Erb et al. (Erb & Stewart, 1999; Erb, Salmaso, Rodaros, & Stewart, 2001), 
have described a pathway involving the activation of CRF neurons in the CeA by stress-
induced NE release, which in turn act on CRF receptors in the BNST and consequently 
drive footshock-induced reinstatement of drug-seeking (Shalev et al., 2002). 
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 As mentioned above, stress and reward pathways in the brain seem to interact to 
produce the affective and behavioral aspects of the stress response. The mesolimbic 
dopamine (DA) pathway which consists of the dopaminergic projections from the ventral 
tegmental area (VTA) to the nucleus accumbens (NAc) and to the prefrontal cortex 
(PFC), is implicated in reward processing (Kelley et al., 2002). It is thought that 
rewarding properties of all drugs of abuse relate to their ability to generate, either directly 
or indirectly, a release of DA in this pathways (Wise, 1998). In addition, an overflow of 
DA in the NAc is observed following footshock-induced reinstatement of heroin seeking 
(Shaham & Stewart, 1995). In agreement with the suggested role of the DAergic system 
in stress-induced reinstatement, systemic administration of a mixed dopamine antagonist, 
flupenthixol attenuates, footshock-induced reinstatement of heroin seeking (Shaham & 
Stewart, 1996). Surprisingly, administration of specific DA D1 or D2-like receptor 
antagonists did not significantly affect footshock stress-induced reinstatement (Shaham & 
Stewart, 1996). However, intracranial infusions of SCH-23390, a D1-like receptor 
antagonist, but not a D2-like receptor antagonist, into the prelimbic or orbitofrontal 
cortex blocked footshock-induced reinstatement of cocaine seeking (Capriles, Rodaros, 
Sorge, & Stewart, 2003), suggesting a critical role for DA transmission in these areas in 
stress-induced reinstatement.  
 It is possible that the CRF and DA brain systems interact to drive stress-induced 
drug seeking behavior. Intra-VTA infusions of a selective CRF1 receptor antagonist, for 
example, block footshock-induced reinstatement of cocaine seeking (Blacktop et al., 
2011). In addition, it has been shown that CRF is released in the VTA following exposure 
to footshock stress (Wang et al., 2005). This release of CRF may in turn modulate 
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glutamate (an excitatory neurotransmitter) release in the VTA, as well as activation of the 
mesolimbic dopamine system. This effect was found to be selective to rats with a history 
of cocaine taking versus naive controls (Wang et al., 2005). It was therefore suggested 
that footshock-induced reinstatement is mediated by a coordinated activation of the CRF 
and DAergic circuitry.  
 The studies described above have contributed a remarkable amount of knowledge 
on the link between stress and relapse, and to the elucidation of the underlying brain 
mechanisms. We, however, believe footshock to be too extreme of an environmental 
stressor, which is hardly relevant to the human condition. We have therefore focused on 
the effects of a more biologically relevant environmental manipulation, exposure to 
caloric restriction. Dietary restriction causes physiological and negative affective states 
that result in increased cortisol levels (Tomiyama et al., 2010) and disrupts neuronal 
pathways that subsequently might augment drug use in human subjects (Franklin, 
Burtrum, Brozek, & Keys, 1948; Hall, Tunstall, Vila, & Duffy, 1992; Hanna & Hornick, 
1977; Krahn, Kurth, Demitrack, & Drewnowski, 1992). In times of war, dietary 
restriction was linked to increases in nicotine and caffeine consumption (Franklin et al., 
1948). Also, malnourished Peruvian Indians were shown to chew more coca leaves 
(Hanna & Hornick, 1977). An increased risk for relapse among calorically restricted 
abstinent smokers (Hall et al., 1992), as well as a positive correlation between the 
severity of diet and the risk of drug taking in young women (Krahn et al., 1992), suggest 
a strong link between dietary restriction and drug intake. 
 Given the demonstrated impact on human drug users (Franklin et al., 1948; Krahn 
et al., 1992), the high comorbidity with eating related disorders (Holderness & Gunn, 
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1994), and their ability to cause disruptions of the stress system, dietary manipulations 
such as acute food deprivation (FD) and food restriction (FDR) seem to be highly 
relevant to the study of relapse. In laboratory animals, the effects of dietary 
manipulations on drug-associated behaviors has been unequivocally demonstrated. The 
initiation and maintenance of drug relapse is reliably enhanced following periods of food 
deficiency (acute FD and food restriction) in the rat (Lu, Shepard, Scott Hall, & Shaham, 
2003; Piazza & Le Moal, 1998). In addition, modifications of reward and stress related 
mechanisms implicated in the resumption of drug seeking, the CRF and DA systems, are 
observed following dietary restriction (Carr, 2002; Shalev, Robarts, Shaham, & Morales, 
2003b). Importantly, acute food deprivation (24-48 h), can induce reinstatement to drug 
seeking in rats with a history of heroin or cocaine self-administration (Shaham et al., 
2003; Shalev, Highfield, Yap, & Shaham, 2000). 
 As with other stressors, food deficiency can increase corticosterone release in 
rodents (Dallman et al., 1999; Marinelli, Le Moal, & Piazza, 1996). In addition, a 
pharmacological blockade or removal of corticosterone can attenuate food restriction-
induced augmentation of the locomotor enhancing effects of psychostimulant drugs 
(Deroche et al., 1995; Marinelli et al., 1996). However, in line with previous findings by 
Shaham and colleagues (1997), CRF receptor antagonism, but not the removal of 
corticosterone, attenuated acute FD-induced reinstatement of drug seeking (Shalev, 
Finnie, Quinn, Tobin, & Wahi, 2006). Finally, similar to footshock-induced 
reinstatement, acute FD-induced reinstatement of drug seeking involves the dopaminergic 
system. However, unlike the former, acute FD-induced reinstatement of heroin seeking 
was attenuated by the systemic administration of the selective DA D1-like, SCH 23390, 
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but not the D2-like, receptor antagonist (Tobin, Newman, Quinn, & Shalev, 2009), 
suggesting that different neuronal mechanisms might underlie reinstatement induced by 
these two stressors. 
 Although acute FD and food restriction can decrease body weight and augment 
drug seeking in rodents, such similarities are accompanied by differential metabolic and 
behavioral effects. For example, gene expression of neuropeptide Y, a peptide known to 
regulate energy balance in response to food intake, is increased in the dorsomedial 
hypothalamus following chronic food restriction but not acute food deprivation (Bi, 
Robinson, & Moran, 2003). Furthermore, Fulton and colleagues (2000) demonstrated a 
decreased threshold for electrical brain stimulation reward in chronically food restricted, 
but not acutely food deprived, rats; this effect was attenuated by leptin, a hormone 
involved in energy balance and metabolism. These studies suggest that differential 
underlying mechanisms may exist between food restriction and food deprivation. 
Additionally, recent studies report an increased risk for relapse among abstinent smokers 
following prolonged food restriction, and not acute food deprivation, suggesting the need 
for a more ecologically valid model of drug relapse (Cheskin, Hess, Henningfield, & 
Gorelick, 2005).  
 The intuitive appeal of the reinstatement model, stemming from the fact that the 
main factors known to trigger relapse in humans also induce reinstatement of drug 
seeking in laboratory animals, has made it the most used animal model of drug relapse 
(Epstein, Preston, Stewart, & Shaham, 2006). Nevertheless, we contend that human 
addicts rarely undergo explicit periods of extinction. Alternatively, addicts experience 
short or prolonged periods of abstinence and withdrawal before the resumption of drug 
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seeking. In addition, recent studies have outlined important differences in the neural 
circuitry involved in abstinence versus extinction learning (Fuchs, 2006; Fuchs, Lasseter, 
Ramirez, & Xie, 2008a). Inactivation of the caudate putamen (Cp), for example, 
attenuates cocaine-seeking following a period of abstinence. However, inactivation of 
other structures that are implicated in the reinstatement of extinguished drug seeking was 
without effect (Fuchs, 2006).  
 Consequently, we suggest a more clinically relevant model, where rats with a 
history of heroin self-administration are tested following prolonged food restriction and 
abstinence. Our model consists of three phases: animals are first trained to self-administer 
a drug in the presence of a cue/tone complex (training phase), then moved to a different 
context and undergo a prolonged period of FDR or remain sated (abstinence phase) and 
finally returned to the self-administration environment for a reward-seeking test in 
presence of drug-paired cues under extinction conditions (test phase). Using this revised 
model, our laboratory has recently reported a dramatic (> 250%) enhancement of heroin-
seeking in food restricted rats, compared to sated controls (D’Cunha, Sedki, Macri, 
Casola & Shalev, 2012). Preliminary evidence suggests an association between changes 
in DA release and the augmentation of heroin seeking following chronic food restriction. 
The role of the DA system in this effect is the subject of an ongoing study in our 
laboratory.  
 Elucidating the mechanisms involved in the food restriction-induced 
augmentation of drug seeking would have a significant contribution to the understanding 
of the way environmental challenges might drive relapse to drugs. Therefore, in the 
experiments described in Chapter 1 of this thesis we investigated the role of stress 
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systems, and more specifically, the involvement of CRF and corticosterone, in the 
augmentation of drug seeking following prolonged food restriction and abstinence. In 
Chapter 2, we report findings with Fos protein immunoreactivity to identify neuronal 
activation in reward and stress related brain regions, following exposure to prolonged 
food restriction and abstinence period. Finally, despite extensive efforts to identify the 
underlying mechanisms involved in drug reward and food restriction, the literature tends 
to target psychostimulant drugs and extinction paradigms, with little emphasis on the 
effects of opiates. Recent reports have outlined the importance of differentiating the 
interpretations made in research using opiates versus psychostimulant drugs (Badiani, 
Belin, Epstein, Calu, & Shaham, 2011). Therefore the studies described here involve rats 
that have been trained to self-administer heroin, an opiate drug. 
General Methods 
Subjects 
 Male, Long-Evans rats (Charles River, St. Constant, Quebec, Canada; 300-350g) 
were used. Before surgery, animals were pair-housed for one week in the animal care 
facility (ACF) under reverse light/dark conditions (lights OFF at 09h30). Following 
intravenous (IV) catheterization, and two days of recovery, rats were single-housed in 
plastic shoebox cages before being transferred to operant conditioning chambers for drug 
self-administration. Following self-administration training, rats were returned to the ACF 
and single-housed in shoebox cages for the abstinence phase. Except for the abstinence 
phase, all rats were given unrestricted access to food and water. Rats were treated 
according to the Canadian Council on Animal Care guidelines, and approval was granted 
by the Concordia University Animal Research Ethics Committee. 
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Surgical procedures 
 Rats were implanted with IV silastic catheters (Dow Corning, Midland, MI, USA) 
under xylazine/ketamine (10+100 mg/kg; i.p.). Three centimeters of silastic catheter was 
inserted through a small incision on the right jugular vein, and secured using silk sutures. 
The remainder of the catheter was passed subcutaneously to the skull, attached to a 
modified 22-gauge cannula (Plastics One Industries, Roanoke, VA) and anchored to the 
skull using dental cement and 5 jeweler’s screws. Post-surgery, animals were 
administered buprenorphine (600 ug/rat; Schering-Plough Ltd., Welwyn Garden City 
Hertfordshire, UK) and penicillin (450,000 IU/rat) to reduce pain and prevent infection. 
Catheters were flushed daily with heparin/gentamicin (7.5 IU + 12.0 mg/rat) to prevent 
blockage and infection. 
Apparatus 
Operant conditioning chambers. Rats were housed individually in operant-conditioning 
chambers (Coulbourn Instruments, Allentown, PA, USA; 29.0 cm x 29.0 cm x 25.5 cm) 
enclosed in sound attenuating wooden compartments equipped with a fan. Each chamber 
consisted of a stainless steel metal grid floor, a front and back Plexiglas wall and two 
metal panel sidewalls. Two retractable levers (Coulbourn Instruments) were mounted 9 
cm above the floor of the right sidewall. Responding on the drug-paired (active) lever 
activated the infusion pump while responding on the non-drug-paired (inactive) lever had 
no programmable consequences. A cue-light (Coulbourn Instruments) and tone module 
(Sonalert, 2.9 KHz, Coulbourn Instruments) were located above the active lever, and a 
red house-light was positioned at the top-center of the left sidewall. The drug pump was 
connected to the catheter via a liquid swivel (Instech Swivel Assembly, Boulder, CO, 
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USA), and Tygon tubing (Norton Performance Plastics, Akron. OH, USA; OD 0.06, ID 
0.02) protected with a metal spring.  
Drug 
 Heroin hydrochloride (HCl) (a contribution from the National Institute for Drug 
Abuse, Research Triangle Park, NC, USA) was dissolved in sterile saline (5.00 mg/ml) 
and then further diluted with saline, for each rat (0.10 mg/kg/infusion).  
Procedure 
Self-administration. Following a 24-h habituation period in the operant chamber, rats 
were trained to self-administer heroin for 10 days with three 3-h sessions separated by 3-
h intervals. Each daily session began shortly after the onset of the dark phase with an 
extension of the active and inactive levers, illumination of a house-light and activation of 
the cue-light/tone complex for 30 s. Responses on the active lever, which was armed with 
a fixed ratio-1 schedule (FR-1), resulted in activation of the drug pump (5 s, 0.13 
ml/infusion) and the initiation of a 20 s timeout during which the house-light was turned 
off and the cue light/tone complex above the active lever was activated. During the 
timeout period, active lever responses were recorded but not reinforced. Following each 
3-h session, the active lever was retracted whereas the inactive lever was not retracted 
until 1 h before the first session of the following day. Inactive lever responses were 
recorded but had no programmable consequences. 
 
Abstinence Phase. Following self-administration training, rats were individually housed 
in the ACF, and given unrestricted access to food and water for one drug-washout day. 
Rats were then divided into two groups: food restricted (FDR) or Sated, that were 
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matched according to body weight, and number of infusions and active lever responses 
across the last 5 days of training. Following the washout day, FDR rats had their food 
removed and were fed approximately 15 g of rat chow at 13h30. The amount of food was 
adjusted through 14 days of food restriction to maintain the food restricted rats’ body 
weight (BW) to approximately 75-80% of the Sated rats and 90% of their baseline BW. 
 
Test Phase. On the morning of abstinence day 14, rats were returned to the operant 
conditioning chambers and attached to the metal spring. The test phase consisted of a 1-h 
session during which active lever responses had the same consequences as in training 
excluding the availability of the drug (see Figure A1 for a timeline of events).






The role of stress systems in chronic food restriction-induced augmentation of 
heroin seeking in the rat.  
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Introduction 
 Stress is often cited as a precipitating factor in drug relapse (Brewer et al., 1998; 
Matheny & Weatherman, 1998; Sinha, 2001; 2008; Sinha & O'Malley, 1999). However, 
the precise mechanisms underlying this effect are not clear. The corticotropin releasing 
factor (CRF), through its actions on hypothalamic and extra-hypothalamic sites, plays a 
critical role in the behavioral and physiological response to stress. Based on the elevation 
of CRF concentrations in the cerebrospinal fluid of clinically depressed patients, it is 
suggested that CRF plays an active role in the modulation of stress and reward-related 
processes (Kehne, 2007). Studies by Heim and colleagues (2008) provide evidence that 
dysregulation of the CRF system in early childhood can cause long-lasting sensitization 
of CRF-mediated stress responses in adults. In addition, manipulations of the CRF system 
exhibit therapeutic value, as treatment with R121919, a selective CRF1 receptor (CRF1-
R) antagonist, can attenuate depressive symptoms (Künzel et al., 2003; O'Brien, Skelton, 
Owens, & Nemeroff, 2001; Zobel et al., 2000). Interestingly, this effect seems to be 
mediated by the actions of treatment on extra-hypothalamic brain regions, as activity of 
the hypothalamic-pituitary-adrenal (HPA) axis stress response remained unaltered during 
testing (Künzel et al., 2003; Zobel et al., 2000). 
 CRF is a 41-amino acid neuropeptide, with two known receptor subtypes: CRF1-R 
and CRF2 -R. Within the HPA axis, the paraventricular nucleus of the hypothalamus 
releases CRF following exposure to stress. At the pituitary gland, CRF acts on the CRF1-
Rs to trigger the synthesis of the adrenocorticotropic hormone (ACTH). ACTH release 
results in the output of cortisol and corticosterone from the adrenal glands. This activates 
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the body’s “fight or flight” response, and drives the body into a state of hyper-alertness 
(Miller & O'Callaghan, 2002). 
 As mentioned before, CRF actions at extra-hypothalamic brain regions might be 
particularly important for its effects on affective and motivational processes. CRF 
positive neurons are found at high densities in the central extended amygdala (CeA), bed 
nucleus of stria terminalis (BNST), brainstem, striatum, ventral tegmental area (VTA), 
and cerebral cortex (Charlton, Ferrier, & Perry, 1987; Cummings, Elde, Ells, & Lindall, 
1983; Swanson, Sawchenko, Rivier, & Vale, 1983; Udelsman et al., 1986; Vale, Spiess, 
Rivier, & Rivier, 1981). The distribution of CRF1-R mRNA is reported across the 
cerebral cortex, basolateral amygdala, medial amygdala, medial septum and BNST, with 
limited expression in the nucleus accumbens and VTA (Potter et al., 1994; Van Pett et al., 
2000). In contrast, CRF2-Rs are predominantly found in subcortical regions; the choroid 
plexus, lateral septum and medial BNST (Bittencourt & Sawchenko, 2000; Chalmers, 
Lovenberg, & De Souza, 1995). Circulating CRF posses a greater affinity for CRF1 and 
not CRF2-Rs. Both, however, are critical to the stress response (Dautzenberg & Hauger, 
2002; Hauger, Risbrough, Brauns, & Dautzenberg, 2006; Hauger, Risbrough, Oakley, 
Olivares Reyes, & Dautzenberg, 2009; Perrin & Vale, 1999; Reul & Holsboer, 2002), as 
CRF2-R activation counteracts increased anxiety-like behaviors observed following 
CRF1-R activation (Risbrough, Hauger, Roberts, Vale, & Geyer, 2004).  
 CRF1-R knockout (KO) mice exhibit diminished anxiety-like behaviors. In 
contrast, CRF2-R KO mice displayed increased levels of anxiety-like behaviors (Bale et 
al., 2000; Kishimoto et al., 2000); however contrasting findings were also reported, with 
CRF2-R KO mice demonstrating an attenuated stress response (Coste et al., 2000). 
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Despite a lack of acute changes in anxiety-like behaviors, CRF2-R KO mice exhibited 
impaired responding under prolonged exposure to stress, which suggests limited 
capabilities in long-term adaptations to stress (Coste et al., 2000; Logrip, Koob, & 
Zorrilla, 2011). These data outline a clear role for CRF1-Rs in the augmentation of stress 
responsivity (Koob & Heinrichs, 1999). CRF2-Rs may play a critical role in adaptation to 
stress, however their role remains unclear and dependent upon differences in research 
methodology (Fekete & Zorrilla, 2007; Ho et al., 2001; Takahashi, Ho, Livanov, 
Graciani, & Arneric, 2001; Zhao et al., 2007). The following study will therefore focus 
on the involvement of the CRF system, and specifically the CRF1-Rs, in drug seeking. 
 The appeal of studying the role of the CRF system in drug addiction is derived 
from the fact that abused drugs have the potential to activate a stress response in the body 
(Sarnyai, 1998; Sarnyai, Shaham, & Heinrichs, 2001), and as discussed in the general 
introduction, exposure to stress is associated with increased drug-taking and drug seeking 
in human subjects (Brown, Vik, & Patterson, 1995; Shiffman & Wills, 1985) and 
laboratory animals (Piazza & Le Moal, 1996; Shaham, Erb, & Stewart, 2000a). For 
example, rodents given extended, but not short-access to cocaine, nicotine, ethanol, or 
heroin self-administration display increased drug taking over time, which can be 
attenuated with treatment of a CRF1-R antagonist (Funk, Zorrilla, Lee, Rice, & Koob, 
2007; George et al., 2007; Greenwell, Funk, Cottone, Richardson, Chen, Rice, Zorrilla, & 
Koob, 2009a; Specio et al., 2007). With respect to drug relapse, administration of a non-
selective CRF-R or selective CRF1-R antagonist can block stress-induced reinstatement 
in rats with a history of cocaine, heroin, alcohol or nicotine self-administration 
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(Bruijnzeel, Prado, & Isaac, 2009; Erb, Shaham, & Stewart, 1998; Gehlert et al., 2007; 
Shaham et al., 1997; Shalev et al., 2006). 
 A common feature shared by all drugs of abuse are somatic withdrawal 
symptoms, an over activation of the physiological stress response (HPA-axis) system and 
increased CRF release from the amygdala. Repeated drug use and prolonged periods of 
abstinence, however, results in a blunted HPA-axis response and an increase in anxiety-
like behaviors. In part, this response is caused by the sensitization of the extra-
hypothalamic CRF stress system (Koob, 2008; Koob & Kreek, 2007). These adaptations 
in the extra-hypothalamic CRF system are accompanied by increased drug craving and 
drug seeking behaviors (Bossert et al., 2005; Bruijnzeel & Gold, 2005; Koob & Zorrilla, 
2010; Logrip et al., 2011). Zorilla and colleagues (2001) report changes in CRF tissue-
content in the amygdala, following protracted abstinence from ethanol or cocaine. In 
addition, exposure to restraint stress in rats which have previously self-administered 
ethanol increases sensitivity and anxiety-like behaviors following a six week abstinence 
period, an effect that was attenuated upon treatment with the non-selective CRF-R 
antagonist, D-Phe CRF12-41 (Valdez, Roberts, Chan, Davis, Brenna, Zorilla, & Koob, 
2002). This provides evidence that abstinence is a dynamic condition, where long-lasting 
changes in neural circuitry continue to occur over time. Moreover, various brain 
adaptations that occur over abstinence have been associated with an increase motivation 
for drug seeking, termed incubation of drug craving, in both humans and animals (Bedi et 
al., 2011; Conrad et al., 2008; Grimm, Hope, Wise, & Shaham, 2001; Lu, Grimm, Hope, 
& Shaham, 2004). Incubation of drug seeking has also been demonstrated with stress-
induced reinstatement of drug seeking. Thus, footshock-induced reinstatement of heroin 
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seeking was higher following 12 or 25 days, compared to one day of abstinence (Shalev, 
Morales, Hope, Yap, & Shaham, 2001a). 
 Recently, we have demonstrated an augmentation of heroin seeking in abstinent, 
chronically food-restricted rats (D’Cunha et al., 2012). The findings presented above, and 
in the general introduction, suggest that over the period of abstinence, exposure to food 
restriction modulates brain adaptations, possibly in stress-related pathways, resulting in 
the augmentation of drug seeking. In the study presented here we investigated the role of 
CRF transmission and HPA axis activation in the augmentation of heroin seeking 
following exposure to 14 days of food restriction in abstinent rats. In the first experiment, 
we studied the effects of acute treatment with the selective CRF1-R antagonist R121919 
or the non-selective CRF-R antagonist, α-helical-CRF before a drug seeking test on food 
restriction-induced augmentation of heroin seeking. The second experiment describes the 
effects of treatment with RU486, a glucocorticoid receptor antagonist, on heroin seeking 
in food restricted, abstinent rats. It was expected that the antagonism of CRF-Rs, more 
specifically of CRF1-Rs would attenuate the augmentation in heroin seeking that is seen 
in rats following chronic food restriction when compared to sated controls. We did not 
expect that the blockade of glucocorticoid receptors would attenuate heroin seeking in the 
food restricted or sated groups as previous research indicated that the corticosterone 
system is not involved in a food deprivation induced reinstatement of heroin seeking 
(Shalev et al., 2006).
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Experiment 1: The role of CRF in chronic food restriction-induced augmentation of 




 Seventy-seven male, Long-Evans rats (Charles River, St. Constant, Quebec, 
Canada; Harlan Laboratories, IN, USA, 300-350g) were used. Rats were housed and 
treated as described in the general methods. 
Surgical procedures 
 As described in the general methods, rats were implanted with IV silastic 
catheters to allow for drug self-administration. Some rats (experiment 1B) were also 
implanted with a 22-gauge guide cannula (Plastics One, Roanoke, VA) aimed 2 mm 
above the right or left lateral ventricle (AP, ± 0.5; ML, +1.4; DV, −3.0; relative to 
bregma) to allow for intracerebroventricular (ICV) infusions. Both cannulae were 
subsequently anchored to the skull using dental cement and 5 jeweler’s screws. Catheters 
were flushed daily with heparin/gentamicin to prevent blockage and infection 
Apparatus 
Operant conditioning chambers. The operant conditioning chambers used were identical 
to those described in the general methods. 
Drug 
 Heroin HCl was prepared as described in the general methods. Experiment 1A: 
R121919, the selective CRF1 receptor antagonist, was kindly supplied by Dr. Kenner 
Rice (National Institute on Drug Abuse, NIH, Baltimore, MD, USA). R121919 was 
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dissolved in a 20% β-Cyclodextrin (Sigma-Aldrich) sterile saline solution to a 
concentration of 10.0 mg/kg and adjusted to a pH of 4.5. R121919 was injected at a final 
dose of 20.0 mg/kg. A solution of 20% β-Cyclodextrin mixed in sterile saline solution 
was used as a vehicle (0.0 mg/kg). The doses for R121919 are based on previous reports 
that observed red (Greenwell, Funk, Cottone, Richardson, Chen, Rice, Zorrilla, & Koob, 
2009b; Gutman, Owens, Thrivikraman, & Nemeroff, 2010) 
 Experiment 1B: The non-selective CRF antagonist, α-Helical CRF (Sigma-
Aldrich), was dissolved in sterile water to a concentration of 5.0 µg/µl or 12.5 µg/µl. α-
Helical CRF was infused over 2 minutes at a rate of 1.0 µg/min for a final dose of 10.0 or 
25.0 µg/rat, ICV. Sterile water was used as a vehicle. The injector (28-gauge, Plastics 
One) extended 2 mm below the implanted guide cannula and was kept in place for 60 s 
after the injection to allow for proper diffusion of the drug. The doses for α-Helical CRF 
are based on previous reports (Baldwin, Rassnick, Rivier, Koob, & Britton, 1991; Krahn, 
Gosnell, Grace, & Levine, 1986; Shalev et al., 2006). 
Procedure 
Self-administration and abstinence phase procedures were similar to those described in 
the general methods, with the exception that for rats in experiment 1B (α-Helical CRF 
infusions), guide cannula placements were verified using an angiotensin II-induced 
(100.0 nmol, ICV) short latency (<60 s) drinking response. 
 
Test Phase. On day 14 of abstinence, in experiment 1A, each rat was given a 
subcutaneous injection of R121919 (0.0, 20.0 mg/kg) 30 min before the test session. For 
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experiment 1B, an ICV infusion of α-Helical CRF (0.0, 10.0 or 25.0 µg/rat) was 
administered 10 min before the test session.  
 
Experiment 1B, Anxiety Test. Since treatment with CRF receptor antagonists did not have 
any effect on heroin seeking following abstinence, we examined the efficacy of the 
treatment using a different paradigm. Previously, α-Helical CRF has reliably shown 
anxiolytic properties (Koob & Heinrichs, 1999). An anxiety test was conducted to ensure 
that α-Helical CRF was effective in decreasing stress and anxiety levels in test rats. Eight 
rats that were fitted with ICV guide cannula and participated in the drug-seeking study, 
were restricted for an additional 8 days following the test phase. On day 8, at 13h30 rats 
were brought into a novel, brightly lit, environment and placed in a white circular arena 
(diameter 137 cm; height 46 cm) with one food pellet in the center. Rats where placed at 
either the north, south, west or east positions of the arena and allowed to explore the 
environment for 10 min. The rats’ behavior was recorded by a video camera. Two 
variables were then scored from the video recordings. The first, latency to consumption, 
was defined as the time for the rat to first consume a portion of the food pellet. The 
second, was number of approaches defined as the number of times a rat approached the 
food pellet until first consumption. 
Statistical Analysis 
 All analysis were conducted using SPSS software (IBM, SPSS Statistics, version 
20). Training data for all rats were analyzed using a within subjects ANOVA, with 
training day (1-10) as the independent variable and active lever responses, inactive lever 
responses or number of infusions as the dependent variable. 
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 Number of responses on the active and inactive levers during the test session were 
analyzed using separate univariate ANOVAs, with antagonist dose (experiment 1A: 0.0, 
20.0 mg/kg; experiment 1B: 0.0, 10.0, 25.0 µg/kg) and feeding condition (FDR, Sated) as 
the independent variables.  
 Two independent samples t-tests were carried out to test the efficacy of α-Helical 
CRF in the anxiety test. The independent variable was antagonist dose (0.0, 25.0 µg/kg) 
of α-Helical CRF. Latency to consumption or number of approaches were the dependent 
variable. The critical cut off point for statistically significant results was p ≤ .05, unless 
otherwise stated. 
Results 
Experiment 1A - The Effects of Treatment with the Selective CRF1 Receptor 
Antagonist, R121919, on Chronic Food Restriction-induced Augmentation of Heroin 
Seeking in the Rat 
 Final analysis included 25 rats. A total of 5 rats were removed due to catheter 
leakage, failure to train, or detached head-cap. The remaining rats acquired reliable 
heroin self-administration behavior. 
 
Training. Mauchly’s test of sphericity assumptions were violated for all training data. All 
values recorded were corrected using the Greenhouse-Geisser correction. A statistically 
significant increase in heroin infusions over time was observed, F (9,216) = 10.76, p < 
.001. Active lever responding increased across training sessions, while there was no 
statistically significant change in inactive lever responding over time, F (9,216) = 10.73, 
p < .001 (see Figure 1). Following the heroin self-administration phase, rats were 
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separated into two groups FDR (n=12) or Sated (n=13) that were matched according to 
the mean number of infusions, active lever responding and body weights over the last 
five days of training. Data on the last day of training is as follows; mean number of 
infusions (M = 42.08, SEM = 4.25), active and (M = 155.72, SEM = 18.97) inactive lever 
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Figure 1. Mean (± SEM) number of infusions, active, and inactive lever responses made 
during heroin self-administration training by rats in experiment 1A (n = 25). Heroin (0.1 
mg/kg/infusion) was self-administered in three 3-h sessions, over 10 days, under a FR1 + 
20 s time out schedule of reinforcement. Infusions and active lever responding increased 
at a statistically significant level (p < .05) over training days, whereas inactive lever 
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Test. The number of rats in each matched experimental group was: FDR-0.0 = 5, FDR-
20.0 = 7, Sated-0.0 = 6, Sated-20.0 = 7. On test day, average body weights of the Sated 
group was statistically significantly greater than the FDR group’s body weight, t (23) = -
10.12, p < .001, (see Figure 2). The mean number of active lever responses performed by 
the rats in the FDR group was almost three times higher than in the Sated group. The 
robust effect was confirmed by a statistically significant main effect of feeding condition, 
F (1,21) = 6.91, p = .016 (see Figure 3). The effect of the treatment with the CRF1 
receptor antagonist, R121919, on the number of active lever responses in the FDR and 
Sated groups is depicted in Figure 4. No statistically significant effects were found for 
antagonist dose or for the interaction feeding condition X antagonist dose.  No 
statistically significant effects were observed for inactive lever responding on test day 
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Figure 2. Mean (± SEM) body weights in the food restricted FDR (n = 12) and Sated (n = 
13) groups, across experimental days for experiment 1A. All rats underwent 10 days 
heroin self-administration training in operant training chambers and 1 day drug washout 
in the animal care facility. Rats were matched according to body weight, active lever 
responding and drug infusions before separation into the FDR or Sated group. On day 14 
of abstinence, rats were returned to the operant training chambers for a 1 h test under 
extinction conditions. * p < .001. 
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Figure 3. The effect of exposure to prolonged food restriction (FDR) on heroin seeking in 
abstinent rats. Data shown are the mean (+ SEM) active and inactive lever responding on 
test day, collapsed over FDR (n = 12) and Sated groups (n = 13) for experiment 1A. Test 
day consisted of one 1-h test session under extinction conditions, following heroin self-
administration training and 14 days of abstinence under FDR or sated conditions. Active 
lever responding was statistically significantly greater for the FDR group versus Sated 
controls. * p = .016.  
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Figure 4. The effect of treatment with R121919 on heroin seeking in food restricted 
(FDR) and sated rats. Data shown are the mean (+ SEM) active lever responding on test 
day, in experiment 1A. Test day consisted of one 1-h test session under extinction 
conditions, following heroin self-administration training and 14 days of abstinence under 
FDR or sated conditions. No statistically significant results were observed across 
antagonist dose (0.0, 20.0 mg/kg) in the FDR (n’s: FDR-0.0 = 6, FDR-20.0 = 7)  or Sated 
(n’s: Sated-0.0 = 5, Sated-20.0 = 7) groups.  
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Figure 5. The effect of treatment with R121919 on heroin seeking in food restricted 
(FDR) and sated rats. Data shown are the mean (+SEM) inactive lever responding on test 
day, in experiment 1A. Test day consisted of one 1-h test session under extinction 
conditions, following heroin self-administration training and 14 days of abstinence under 
FDR or sated conditions. No statistically significant results were observed across 
antagonist dose (0.0, 20.0 mg/kg) in the FDR (n’s: FDR-0.0 = 6, FDR-20.0 = 7)  or Sated 
(n’s: Sated-0.0 = 5, Sated-20.0 = 7) groups.
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Experiment 1B - The Effects of Treatment with the Non-selective CRF Receptor 
Antagonist, α-Helical CRF, on Chronic Food Restriction-induced Augmentation of 
Heroin Seeking in the Rat 
 Final analysis included 52 rats. A total of 8 rats were removed due to catheter 
leakage, failure to train or detached head-caps. The remaining rats acquired reliable 
heroin self-administration behavior. 
 
Training. Mauchly’s test of sphericity assumptions were violated for all training data. All 
values recorded were corrected using the Greenhouse-Geisser correction. A statistically 
significant increase in heroin infusions over time was observed, F (9,459) = 25.14, p < 
.001. Active lever responding increased across training sessions, F (9,459) = 12.52, p < 
.001, while no statistically significant change in inactive lever responding was found. 
Following the heroin self-administration phase, rats were separated into two groups FDR 
(n=26) or Sated (n=26) that were matched according to mean number of infusions, active 
lever responding and body weights over the last five days of training. Data on the last day 
of training is as follows; mean number of infusions (M = 35.06, SEM = 1.91), active and 
(M = 99.62, SEM = 13.40) inactive lever (M = 6.90, SEM = 0.84) responses. 
 
Test. The number of rats in each matched experimental group was: FDR-0.0 = 8, FDR-
10.0 = 11, FDR-25.0 = 7, Sated-0.0 = 10, Sated-10.0 = 11, Sated-25.0 = 5. On test day, 
average body weights of the Sated group (n = 26, M = 439.62, SEM = 9.27) were 
statistically significantly greater than the FDR groups (n = 26, M = 333.08 SEM = 4.17) 
body weights, t (50) = -10.48, p < .001. Rats in the FDR group made a higher number of 
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responses on the active lever during the test, compared to the Sated group. This finding 
was supported by a statistically significant main effect of feeding condition, F (1,46) = 
17.68, p < .001 (see Figure 6). Figure 7 shows effects of the treatment with the non-
selective CRF receptor antagonist, α-Helical CRF, on the number of active lever 
responses in the FDR and Sated groups. No statistically significant effects were found for 
antagonist dose or for the interaction feeding condition X antagonist dose. No significant 
effects were observed for inactive lever responding on test day (see Figure 6 & 8).
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Figure 6. The effect of exposure to prolonged food restriction (FDR) on heroin seeking in 
abstinent rats. Data shown are the mean (+SEM) active and inactive lever responding on 
test day, collapsed over FDR (n = 26) and Sated groups (n = 26) for experiment 1B. Test 
day consisted of one-1 h test session under extinction conditions, following heroin self-
administration training and 14 days of abstinence under FDR or sated conditions. Active 
lever responding was statistically significantly greater for the FDR group versus Sated 
control. * p < .001. 
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Figure 7. The effect of treatment with α-Helical CRF on heroin seeking in food restricted 
(FDR) and sated rats. Data shown are the mean (+ SEM) active lever responding on test 
day, in experiment 1B. Test day consisted of one 1-h test session under extinction 
conditions, following heroin self-administration training and 14 days of abstinence under 
FDR or sated conditions. No statistically significant results were observed across 
antagonist dose (0.0, 10.0, 25.0 μg/kg) in the FDR (n’s: FDR-0.0 = 8, FDR-10.0 = 11, 
FDR-25.0 = 7) or Sated (n’s: Sated-0.0 = 10, Sated-20.0 = 11, Sated-20.0 = 5) groups.
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Figure 8. The effect of treatment with α-Helical CRF on heroin seeking in food restricted 
(FDR) and sated rats. Data shown are the mean (+SEM) inactive lever responding on test 
day, in experiment 1B. Test day consisted of one 1-h test session under extinction 
conditions, following heroin self-administration training and 14 days of abstinence under 
FDR or sated conditions. No statistically significant results were observed across 
antagonist dose (0.0, 10.0, 25.0 μg/kg) in the FDR (n’s: FDR-0.0 = 8, FDR-10.0 = 11, 
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Anxiety Test. An independent samples t-test revealed a statistically significant decrease in 
latency to first consumption in the α-Helical CRF group versus vehicle controls, t (5) = 
2.80, p = .038 (see Figure 9). A similar pattern was observed for number of approaches 
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Figure 9. The effect of treatment with α-Helical CRF on anxiety measures in an open 
arena test in experiment 1B, following an 8 day food restriction period. Data shown are 
the mean (+ SEM) latencies to first consumption of a food pellet placed at the center of 
an open arena following injections of α-Helical CRF (0.0, 25.0 μg/kg; ICV), in food 
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Figure 10. The effect of treatment with α-Helical CRF on anxiety measures in an open 
arena test in experiment 1B, following an 8 day food restriction period. Data shown are 
the mean (+ SEM) number of approaches to a food pellet placed in the center of an open 
arena prior to first consumption, following treatment with α-Helical CRF (0.0, 25.0 
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Experiment 2: The role of corticosterone in chronic food restriction-induced 
augmentation of heroin seeking in the rat. 
 
Methods                                                                                                                                                                                                            
Subjects 
 Twenty-seven male, Long-Evans rats (Charles River, St. Constant, Quebec, 
Canada; 300-350g) were used. Rats were housed and treated as described in the general 
methods. 
Surgical procedures 
 Rats were implanted with IV silastic catheters to allow for drug self-
administration, as described in the general methods. Catheters were flushed daily with 
heparin/gentamicin to prevent blockage and infection. 
Apparatus 
 The apparatus used was identical to that described in the general methods. 
Drug 
 Heroin HCl was prepared as described in the general methods. RU486, a 
glucocorticoid receptor antagonist, was dissolved using a 25% β-Cyclodextrin (Sigma-
Aldrich), 20% Dimethyl Sulfoxide (Fisher Scientific), 1% tweenⓇ 80 (INFO) and sterile 
water mixture. RU486 was adjusted to a pH of approximately 5.6 and injected intra 
peritoneal (IP) at a dose of 30 mg/kg. 
Procedure 
Self-administration training and abstinence phases procedures were identical to those 
described in the general methods.  
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Test Phase. On the morning of abstinence day 14, rats were given IP injections of RU486 
(30.0 mg/kg) or vehicle. Rats were returned to the operant conditioning chambers and 
attached to the metal spring 45 min following the IP injections.  
Plasma Corticosterone Determination 
 Immediately following the test phase (10h30), tail blood was collected, plasma 
was separated by centrifuge (Microlite RF Microcentrifuge, Thermo Fisher Scientific, 
Nepean, ON, Canada) at 10,000 rpm for 10 min. Samples were stored at -80℃. Plasma 
samples were analyzed for corticosterone levels using a corticosterone specific enzyme-
linked immunosorbent assay (ELIZA) kit (Enzo Life Sciences: Cedarlane, Burlington, 
ON, Canada).  
Statistical Analysis 
 All analysis were conducted using SPSS software (IBM, SPSS Statistics, version 
20). Training data for all rats were analyzed using a within subjects ANOVA, with 
training day (1-10) as the independent variable and active lever responses, inactive lever 
responses or number of infusions as the dependent variable. 
 Number of responses on the active and inactive levers during the test session were 
analyzed using a univariate ANOVA. Antagonist dose (0.0, 30.0 mg/kg) and feeding 
condition (FDR, Sated) served as the independent variables. 
 Plasma corticosterone levels (pg/ml), sampled following the test session, were 
analyzed using a univariate ANOVA. Antagonist dose (0.0, 30.0 mg/kg) and feeding 
condition (FDR, Sated) served as the independent variables. A statistically significant 
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interaction was followed by appropriate post hoc tests. The critical cut of point for 
statistically significant results was p ≤ .05. 
Results 
 Final analysis included 27 rats. Three rats were removed due to catheter leakage, 
failure to train or detached head-caps. The remaining rats acquired reliable heroin self-
administration behavior. 
 
Training.  Mauchly’s test of sphericity assumptions were violated for all training data. 
All values recorded were corrected using the Greenhouse-Geisser correction. A 
statistically significant increase in heroin infusions over time was observed, F (9,234) = 
14.38, p < .001. Active lever responding  increased across training sessions, F (9,234) = 
12.16, p < .001, while no statistically significant change in inactive lever responding was 
observed. Data on the last day of training is as follows: mean number of infusions (M = 
39.89, SEM = 4.44), active and (M = 141.11, SEM = 22.57) inactive lever (M = 17.41, 
SEM = 7.98) responses. 
 
Test. The number of rats in each matched experimental group was: FDR-0.0 = 7, FDR-
30.0 = 7, Sated-0.0 = 8, Sated-30.0 = 5. On test day, average body weights of the Sated 
group (n = 13, M =  426.23, SEM = 28.93) were statistically significantly greater than the 
FDR group’s (n =14 M = 317.36, SEM = 19.50) body weight, t (25) = -11.54, p < .001. 
As can be seen in Figure 11, the FDR group showed a statistically significant increase in 
active lever responding compared to the Sated group, (feeding condition effect: F (1,23) = 
8.46, p =.008). No statistically significant effects for antagonist dose or the interaction 
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feeding condition X antagonist dose were observed, (see Figure 12). A statistically 
significant increase in inactive lever responding for the FDR group versus the Sated 
group was also found, F (1,23) = 6.42, p =.019 (see Figure 11). No other statistically 
significant effects were found for inactive lever responses (see Figure 13).
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Figure 11. The effect of exposure to prolonged food restriction (FDR) on heroin seeking 
in abstinent rats. Data shown are the mean (+ SEM) active and inactive lever responding 
on test day, collapsed over FDR (n = 14) and Sated groups (n = 13) for experiment 2. 
Test day consisted of one 1-h test session under extinction conditions, following heroin 
self-administration training and 16 days of abstinence under FDR or sated conditions. 
Active and inactive lever responding was statistically significantly greater for the FDR 
group versus Sated controls. * p = .008; & p = .019.
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Figure 12. The effect of treatment with RU486 on heroin seeking in food restricted 
(FDR) and sated rats. Data shown are the mean (+SEM) active lever responding on test 
day, in experiment 2. Test day consisted of one 1-h test session under extinction 
conditions, following heroin self-administration training and 16 days of abstinence under 
FDR or sated conditions. No statistically significant results were observed across 
antagonist dose (0.0, 30.0 mg/kg) in the FDR (n’s: FDR-0.0 = 7, FDR-30.0 = 7) or Sated 
(n’s: Sated-0.0 = 8, Sated-30.0 = 5) groups. 
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Figure 13. The effect of treatment with RU486 on heroin seeking in food restricted 
(FDR) and sated rats. Data shown are the mean (+SEM) inactive lever responding on test 
day, in experiment 2. Test day consisted of one 1-h test session under extinction 
conditions, following heroin self-administration training and 16 days of abstinence under 
FDR or sated conditions. No statistically significant results were observed across 
antagonist dose (0.0, 30.0 mg/kg) in the FDR (n’s: FDR-0.0 = 7, FDR-30.0 = 7) or Sated 
(n’s: Sated-0.0 = 8, Sated-30.0 = 5) groups.
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Plasma Corticosterone Determination. Analysis of plasma corticosterone levels taken 
immediately following the test session revealed a statistically significant interaction 
between feeding condition and antagonist dose, F (1, 15) = 7.15, p = .017. Independent 
samples post-hoc t-tests with a Bonferroni-adjusted α = .025, revealed a statistically 
significant increase in corticosterone levels in rats treated with 30.0 mg/kg RU486 versus 
the 0.0 mg/kg dose for the FDR group, t (7) = -2.99, p = .020. A similar effect was 
observed in the Sated group, t (8) = -5.59, p = .001, (see Figure 14).  
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Figure 14. The effect of treatment with RU486 on corticosterone levels in experiment 2. 
Data shown are the mean (+SEM) corticosterone levels (pg/ml) immediately following a 
test session under extinction conditions after infusions of  RU486 (0.0, 25.0 μg/kg; ICV), 
in food restricted rats (n’s: 0.0 = 12, 30.0 = 7) and Sated rats (n’s: 0.0 = 8, 30.0 = 5). * p 
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Summary 
 A robust increase in heroin seeking was observed in food restricted, compared to 
sated rats, when animals were returned to the heroin self-administration environment. In 
contrast to our hypothesis, this augmentation in heroin seeking was not attenuated by 
treatment with a selective CRF1 or non-selective CRF receptor antagonist. Additionally, 
glucocorticoid receptor antagonism had no effect on the augmentation of heroin seeking 
in food restricted, abstinent rats. 
 Consequently, the goal of the experiment in Chapter 2 was to investigate neuronal 
activation in brain areas implicated in reward-related processes and drug seeking. 
Identifying brain sites involved in the augmentation of heroin seeking following 
prolonged food restriction will offer neural targets for future studies, indented to 
elucidate the underlying mechanisms of our effect.






The effects of chronic food restriction on Fos immunoreactivity in the nucleus 
accumbens in heroin seeking rats.  
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Introduction 
 There is evidence that stress has an important influence on drug taking and drug 
reward (Carr, 2002; Shalev, Marinelli, Baumann, Piazza, & Shaham, 2003a). Recently, 
we reported an augmentation of heroin seeking in abstinent, chronically food-restricted 
rats (D’cunha et al., 2012). However, this effect was not attenuated by acute manipulation 
of the corticotropin releasing factor (CRF) or corticosterone stress systems (Chapter 1). 
This indicates that an acute physiological stress-response is not critically involved in the 
augmentation of heroin seeking following prolonged food restriction. Here we present an 
exploratory study aimed at the identification of relevant brain sites, as the neural 
mechanisms mediating this effect remain elusive. 
 Drugs of abuse exert their effects by acting upon neuronal circuitry that evolved 
to encourage species survival such as feeding and mating (Balfour, Yu, & Coolen, 2004; 
Glickman & Schiff, 1967; Kelley & Berridge, 2002; Wise & Bozarth, 1985). The 
mesocorticolimbic dopamine (DA) circuit is strongly implicated in appetitive motivation 
and the learned aspects of addictive behavior, with considerable evidence supporting its 
involvement in the rewarding properties of natural stimuli and abused drugs (Berridge & 
Kringelbach, 2008; Feltenstein & See, 2008; R. Wise, 1996). Additionally, it is thought 
that stress has a modulatory role on this pathway. The mesocorticolimbic DA circuit 
contains cell bodies in the ventral tegmental area which project to limbic structures, such 
as the amygdala and nucleus accumbens (NAc), as well as cortical areas such as the 
medial prefrontal cortex (mPFC). Here, we chose to investigate brain sites that are 
involved in stress and reward related processes; the amygdala, nucleus accumbens (NAc), 
and medial prefrontal cortex (mPFC). 
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 Importantly, the amygdala exhibits increased levels of CRF (Cook, 2004) 
following exposure to stress. Furthermore, disconnecting CRF-containing projections 
from the central nucleus of the amygdala (CeA) to the bed nucleus of the stria terminalis 
(BNST), results in a blockade of footshock stress-induced reinstatement of cocaine 
seeking (Erb et al., 2001). Together, these studies support the notion that the amygdala is 
involved in stress responsivity, as well as the motivational processing of conditioned drug 
rewards. McFarland and colleagues (2004) provide further evidence that the amygdala is 
involved in the modulation of conditioned drug rewards. For example, inhibition of the 
CeA via local injections of gamma aminobutyric acid (GABA) receptor agonists 
attenuated footshock-induced reinstatement of cocaine seeking. Another sub-region of the 
amygdala, the basolateral amygdala (BLA), mediates the effects of exposure to drug-
associated cues on drug seeking. Transient inactivation of the BLA can block cue-
induced reinstatement of cocaine and heroin seeking (Fuchs & See, 2002; Grimm & See, 
2000), while excitotoxic lesions of the BLA can disrupt the incentive properties of 
conditioned stimuli (Meil & See, 1997; Whitelaw, Markou, Robbins, & Everitt, 1996). 
This suggests that while the primary reinforcing properties of the drug itself are 
unaffected by lesions of the BLA, the ability to acquire a learned behavior which is 
reinforcing as a result of its association with the drug, the primary reinforcer, (second-
order conditioning) is disrupted (Meil & See, 1997; Whitelaw et al., 1996). Yun and 
colleagues (2003) demonstrated that in addition to the attenuation of cocaine-induced 
reinstatement, lesions of the BLA impair a rodents ability to distinguish cues which 
predict the availability of a cocaine reward. In contrast with the inactivation of the BLA, 
activation by means of a brief 20 Hz electrical stimulation or NMDA-induced chemical 
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stimulation results in the reinstatement of cocaine seeking (Hayes, Vorel, Spector, Liu, & 
Gardner, 2003). Additionally, heightened neuronal activation, assessed through the 
expression of the immediate early gene c-fos, in the BLA, is associated with cue-induced 
reinstatement of ethanol seeking (Jupp, Krstew, Dezsi, & Lawrence, 2011; Schroeder et 
al., 2008). While the BLA is critical to the acquisition of learned stimulus-reward 
associations, as well as the expression of cue-induced cocaine seeking, lesions of the CeA 
are instead implicated only in the expression, but not the acquisition of these behaviors 
(Kruzich & See, 2001). Taken together, these studies strongly implicate the amygdala in 
responding not to the drug rewards, but to acquisition of and responses to conditioned 
stimuli that were associated with drug rewards. 
 Studies have unequivocally demonstrated a role for the NAc in reward-related, 
goal-directed and drug seeking behaviors (Bossert et al., 2005; Carlezon & Thomas, 
2009; Fuchs, Ramirez, & Bell, 2008b). Moreover, the finding that experiencing stress 
during development alters spine density, dendritic length, and branching in the NAc 
suggests a role for the NAc in stress control (Muhammad, Carroll, & Kolb, 2012). With 
respect to drug rewards, lesions of the NAc have been found to reduce the self-
administration of cocaine, morphine and heroin (Dworkin, Guerin, Co, Goeders, & 
Smith, 1988; Zito, Vickers, & Roberts, 1985). Additionally, following inactivation of the 
NAc, a reduction in context- and priming-induced reinstatement of cocaine seeking is 
observed (Fuchs, Ramirez, & Bell, 2008b; Grimm & See, 2000). A reduction in cue-
induced heroin seeking and ethanol renewal, i.e., the return to drug seeking in a 
previously drug paired context following extinction in a different context ethanol seeking, 
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has also been reported following transient inactivation of the NAc (Chaudhri, Sahuque, 
Schairer, & Janak, 2009; Rogers, Ghee, & See, 2008). 
 Two anatomically and functionally distinct sub-compartments of the NAc; the 
core (NAcC) and the shell (NAcS), have been identified. The NAcC is necessary for 
motor control and the expression of learned behaviors, while the NAcS is implicated in 
limbic aspects such as sensory, emotional control as well as ingestive behaviors (Kelley, 
2004). These sub-regions seems to be critically involved in the reinstatement of 
extinguished drug seeking. Thus, blockade of DA D1-receptors in the NAcS, or 
interfering with glutamate release in this area by injection of an mGluR2/3 agonist, 
attenuates context-induced reinstatement of heroin seeking (Bossert, Poles, Sheffler-
Collins, & Ghitza, 2006; Bossert, Poles, Wihbey, Koya, & Shaham, 2007). Additionally, 
antagonizing mGluR1 or AMPA/kainate receptors in the NAcC impairs the expression of 
context-induced cocaine seeking in rats (Xie et al., 2011), and an increase in glutamate 
release in the NAcC is required for the reinstatement of cue-induced heroin seeking 
(LaLumiere & Kalivas, 2008). Finally, the blockade of DA D1-receptors in the NAcC 
attenuated the reinstatement of discrete cue-, but not context-induced heroin seeking 
(Bossert et al., 2007). Differential roles for these sub-regions was also reported with 
ethanol seeking, where inactivation of the NAcS, but not the NAcC attenuated contextual 
renewal of ethanol seeking (Chaudhri et al., 2009). An important role has been suggested 
for the NAc in stress-induced reinstatement as well, as inactivation of the NAcS or NAcC 
can inhibit footshock-induced reinstatement (McFarland et al., 2004).    
 Finally, the prefrontal cortex (PFC) is known to be important for reward seeking. 
Generally, the prefrontal cortex is linked to executive functioning (Rossi, Pessoa, 
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Desimone, & Ungerleider, 2009). This includes the organization of thoughts and actions 
necessary for goal-related behaviors, the regulation of appetite, and more specifically the 
acquisition of instrumental learning (Fregni et al., 2008; McLaughlin & See, 2003). 
Furthermore, as a result of repeated exposure to cocaine, adaptations in dendritic spine 
shape are reported in the PFC (Robinson, Gorny, Mitton, & Kolb, 2001). These region-
specific alterations may contribute to dysfunctions in executive control and decision 
making, a hallmark of drug addiction.   
 Several sub-sections of the PFC have been implicated in drug reward-related 
processes. The prelimbic (pl-PFC) and infralimbic (il-PFC) cortices appear to mediate 
different aspects of behavior; the il-PFC is involved in habitual, persistent behaviors and 
the pl-PFC is involved in the acquisition of drug seeking behavior and the reacquisition 
of drug-taking after extinction (Di Ciano, Benham-Hermetz, Fogg, & Osborne, 2007). 
For example, an attenuation of discrete cue-, cocaine-priming, and stress-induced 
reinstatement is achieved through inactivation of the pl-PFC, but not the il-PFC (Capriles 
et al., 2003; McFarland & Kalivas, 2001; J. McLaughlin & See, 2003). The attenuation of 
context-induced reinstatement, however, was demonstrated by inactivation of the il-PFC 
(Bossert et al., 2011). The pl-PFC is implicated in stress-induced reinstatement, as greater 
activation in this region is observed following acute-food deprivation induced heroin 
seeking (Shalev, Robarts, Shaham, & Morales, 2003b). In a conditioned place preference 
paradigm, however, rats with a greater preference for the cocaine paired context had 
reduced levels of neural activation of the pl-PFC when compared to low preference or 
non-drug conditioned control rats (Zombeck et al., 2008).  
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 The findings described above suggest that the mesocorticolimbic DA circuitry, 
including the amygdala, NAc, and mPFC is critically involved in drug and non-drug 
reward seeking. Thus, the goal of the present study, was to investigate whether these 
brain sites that are potentially involved in food restriction-induced augmentation of 
heroin seeking in abstinent rats. 
 To that end, we used Fos protein immunoreactivity (Fos-IR) to identify neurons 
that are activated by re-exposure to the drug self-administration context and cues in food 
restricted and sated rats, during tests for heroin seeking following prolonged abstinence. 
The immunohistochemical localization of Fos (the protein product of the immediate early 
gene c-fos) is commonly used to study neuronal activity following environmental and 
pharmacological manipulations (Morgan & Curran, 1991). Fos-IR was previously used 
for the identification of brain sites that are involved in cue, or stress-induced 
reinstatement of drug seeking (Neisewander, O'Dell, Tran-Nguyen, Castañeda, & Fuchs, 
1996; Shalev, Robarts, Shaham, & Morales, 2003b), and in chronic food restriction-
induced increases in behavioral responsiveness to drugs of abuse (Carr, 2002). 
 Four control groups were included in the current study. Fos-IR was determined in 
groups of drug-naive rats under sated or food restricted conditions to assess the effects of 
food restriction per se on neuronal activation. In addition, since active extinction of drug 
seeking alters brain adaptations induced by previous exposure to drugs (Self & Choi, 
2004; Sutton et al., 2003), we also assessed neuronal activation in heroin-trained sated or 
food restricted rats that were not exposed to the drug-seeking test session. 
 Fos-IR was examined in the BLA, CeA, NAcS and NAcC, the pl-PFC and il-PFC, 
all brain sites that are involved in stress and reward. It was expected that, across all 
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experimental conditions, exposure to a prolonged period of food restriction would result 
in increased activation compared to rats allowed unrestricted access to chow, and that 
Fos-IR would be highest in the heroin-trained food restricted rats that were exposed to the 
drug-seeking test. 
Methods   
Subjects 
 Forty-three male Long-Evans rats (Charles River, St. Constant, Quebec, Canada; 
300-350g) were used. Rats were housed under conditions specified in the general 
methods section. 
Surgical procedures 
 As described in the general methods, rats were implanted with IV silastic 
catheters to allow for drug self-administration. Catheters were flushed daily with 
heparin/gentamicin to prevent blockage and infection. 
Apparatus 
Operant conditioning chambers. Heroin training was conducted in operant-training 
chambers identical to those described in the general methods. 
 
Drug 
 Heroin HCl was prepared as described in the general methods. 
Procedure 
 The experiment included 3 major groups of rats. The first, heroin-trained-tested 
group (n=25), was exposed to the heroin self-administration training, abstinence, and test 
phases as described in the general methods. The second, heroin-trained-no-test group 
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(n=8), was treated similarly to the first group, except that the rats were sacrificed without 
being tested for drug seeking at the end of the abstinence period. Rats in the third, drug-
naive group (n=10), remained in the ACF for the entirety of the experiment. Each group 
was further divided into food restricted (FDR) and sated sub-groups. Food restricted rats 
were restricted throughout the abstinence phase (or a 14-day period for the naive rats), as 
described in the general methods, aiming to keep their mean body weight at 80% of the 
sated rats’. Rats were sacrificed immediately after their test session (heroin-trained-tested 
group) or at the approximate time the test session would have ended (heroin-trained-no-
test and drug-naive groups), at approximately 10:30 AM. 
Immunohistochemistry 
  Following the test session, rats were injected with Euthanyl (Sodium 
Pentobarbital, 64.8mg/ml), transcardially perfused using 4% paraformaldehyde and 
phosphate buffered saline (NaH2PO4; sodium phosphate monobasic, NaOH; salt pellets, 
distilled water) and then decapitated. Brains were extracted, preserved in a solution of 4% 
paraformaldehyde for 48 h and then sliced to obtain 40 μm sections on a vibratome 3000 
Deluxe (Harvard Apparatus Canada, Saint-laurent, QC, CA). Tissue was sliced and 
collected according to coordinates provided by the Paxinos & Watson (2005) atlas. 
Nucleus accumbens (NAc) tissue slices ranged from 3.24 to 1.20 in relation to bregma. 
Amygdala tissue slices ranged from -1.56 to -3.48 in relation to bregma. Tissue sections 
were washed used Trizma Buffered Saline and placed in 4°C for 90 min in a solution of 
Trizma Buffered Saline/Milk Buffer (TBS-M), Triton X-100 and Normal Goat Serum 
(NGS). Tissue sections were then placed in a solution of NGS, TBS, Tritron X-100 and 
the primary antibody (rabbit anti-c-Fos antibody: Calbiochem, San Diego, CA) at 4°C, 
  59 
for  48 h. Tissue sections were washed in TBS, and placed in a mixture of hydrogen 
peroxide (H2O2) and TBS for 30 min in 4°C to reduce nonspecific binding. Next, sections 
were washed in TBS and incubated in a solution of TBS, Biolinylated Anti-rabbit IgG 
(secondary antibody), NGS and Triton X-100 at 4°C. After rinsing with TBS, sections 
were incubated in avidin-biotinylated horseradish peroxidase (Vectastain ABC kit, 
Vector Laboratories, Burlington, ON, CA ). Slices were then rinsed in TBS and 
developed in a solution of 3, 3-diaminobnzidine-4 HCl (DAB), H2O2 and Nickel Chloride 
for 1 min and 30 sec. Slices were mounted on slides, air dried, dehydrated with ethanol, 
and cover slipped. 
Image Analysis 
 Immunolabeled sections were examined using a Leica DMLA Microscope (Leica 
Microsystems, Germany) and a Qimaging Fast 1394 Camera (Surrey, BC). Image J 
(Wayne Rasband, National Institude of Health, Bethesda, Maryland, U.S.) was used for 
capturing brain images at 10x magnification and quantifying Fos protein 
immunoreactivity. A built in Yen protocol was used to quantify cell counts. Cell 
Circularity (.3-1) and cell size (30-150 pixels2) were adjusted for greater accuracy. The 
brain regions of interest were identified based on the Paximus and Watson atlas (2005). 
To account for variability in region size, each relevant brain region was manually traced 
and its area determined by the software. c-Fos immunoreactivity (IR)-labeled nuclei 
counts were divided by their respective areas and multiplied by 106. The 6 brain slices 
representing the highest Fos protein IR in each brain for each rat area were chosen for 
statistical analysis (see Figure 15). The means of these top 6 slices for each rat were used 
in the final analysis.


















Figure 15. Fos protein IR-labeling in the nucleus accumbens shell (NAcShell) and 
ventricles (V) in the heroin-trained-tested condition. A (upper panel): pictograph of 
representative tissue slice from the food restricted (FDR) group (n = 11). B (lower panel): 
pictograph of representative tissue slice from the Sated group (n = 14). Following self-
administration training, on abstinence day 14, rats were immediately sacrificed following 
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Statistical Analyses 
 All analysis were conducted using SPSS software (IBM, SPSS Statistics, version 
20). Training data for the heroin-trained tested group and the heroin-trained-abstinence 
group were analyzed using a within subjects ANOVA, with training day (1-10) as the 
independent variable and active lever responses, inactive lever responses or number of 
infusions as the dependent variable. 
 Number of responses on the active and inactive levers for the heroin-trained-
tested group during the test session were analyzed using an independent samples t-test 
with feeding condition (FDR, Sated) as the independent variables. 
 Three a priori, independent samples t-tests were carried out for each group 
(heroin-trained-tested, heroin-trained-no-test, drug-naive), across all brain region 
(NAcShell, NAcCore, basolateral amygdala (BLA) and central nucleus of the amygdala 
(CeA)) to compare the level of Fos protein IR.  Feeding condition (FDR, Sated) served as 
the independent variable while Fos levels adjusted for region size served as the dependent 
variable. The critical cut-off point for statistically significant results was p ≤ 0.05, with 
the exception of the Fos protein comparisons, where analysis in each brain region used a 
Bonferronni adjusted alpha level of α = .017. 
Results 
 Final analysis included a total of 43 rats. (heroin-trained-tested, n = 25; heroin-
trained-no-tests n = 8; drug-naive, n = 10). Seven rats were removed due to catheter 
leakage, failure to train or issues during the perfusion process. The remaining rats 
acquired reliable heroin self-administration behavior. 
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Behavioral Analysis 
Heroin-trained-tested group 
Training. Mauchly’s test of sphericity assumptions were violated for all training data. All 
values recorded were corrected using the Greenhouse-Geisser correction. A statistically 
significant increase in heroin infusions over time was observed, F (9,270) = 12.70, p < 
.001. Active lever responding  increased across training sessions F (9,270) = 5.67, p = 
.006, while no statistically significant change in inactive lever responding was found. 
Since some rats were removed from the analysis after the group matching was conducted 
(due to inadequate brain perfusion), last five days of training data was used to compare 
the rats assigned to the FDR (n=11) and Sated (n=14) groups. No statistically significant 
differences were found across all criteria: number of infusions, active lever responding 
and body weights. 
 
Test. On test day, average body weights of the Sated group (M = 499.92, SEM = 34.85) 
were statistically significantly greater than the FDR groups (M = 335.18, SEM = 16.95) 
body weights, t (22) = -10.81, p < .001. Furthermore, the FDR group showed a 
statistically significant increase in active lever responding compared to the Sated group, t 
(23) = 5.21, p < .001 (see Figure 16). No statistically significant difference was observed 
for inactive lever responding (see Figure 16).
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Figure 16. The effect of exposure to prolonged food restriction (FDR) on heroin seeking 
in abstinent rats. Data shown are the mean (+SEM) active and inactive lever responding 
on test day, for the FDR (n =11) and Sated groups (n = 14) for experiment one. Test day 
consisted of one 1-h test session under extinction conditions, following heroin self-
administration training and 14 days of abstinence under FDR or sated conditions. Active 
lever responding was statistically significantly greater for the FDR group versus sated 
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Heroin-trained-no-test group 
Training. Mauchly’s test of sphericity assumptions were violated for all training data. All 
values recorded were corrected using the Greenhouse-Geisser correction. The number of 
infusions increased over training days, and repeated measures ANOVA revealed a 
statistical trend, F (9,63) = 3.36, p = .075. Active lever responding did not result in an 
overall increase across training sessions, F (9,63) = 1.60, p = .245 as there was a peak in 
responding half way through the training period, which obscured a progressive increase 
over time. No statistically significant change in inactive lever responding was observed. 
Since some rats were removed from the analysis after the group matching was conducted 
(due to inadequate brain perfusion), last five days of training data was used to compare 
the rats assigned to the FDR (n=3) or Sated (n=5) groups. No statistically significant 
differences were found across all criteria; infusions, active lever responding and body 
weights.  
 
Sacrifice day. On abstinence day 14, average body weights of the Sated group (M = 
448.40, SEM = 26.43) were statistically significantly greater than the FDR groups (M = 
347.33, SEM = 9.29) body weights, t (6) = -6.23, p = .001. 
 
Drug-naive group 
 Following an 11 day period of unrestricted access to food in the ACF care facility, 
rats were separated into two groups, FDR (n=5) or Sated (n=5), matched according to 
mean body weights of the last five days. On day 25 in the ACF, average body weights of 
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the Sated group (M =472.00, SEM = 52.39) were statistically significantly greater than 
the FDR groups (M = 369.60, SEM = 28.06) body weights, t (8) = -3.85, p = .005. 
 
Immunohistochemical Analysis 
Nucleus accumbens shell. A statistically significant decrease in the number of Fos protein 
IR-labeled cells was observed for the FDR group, versus the Sated group, in the heroin-
trained-tested rats, t (23) = -2.65, p = .014. No statistically significant differences were 
observed in the heroin-trained-no-test or drug-naive groups (see Figure 17). 
 
Nucleus accumbens core. No statistically significant differences in Fos protein IR-
labeling were observed in the heroin-trained-tested, heroin-trained-no-test or drug-naive 
groups (see Figure 18). 
 
Basolateral amygdala. No statistically significant differences in Fos protein IR-labeling 
were observed in the heroin-trained-tested, heroin-trained-no-test or drug-naive groups 
(see Figure 19). 
 
Central amygdala. No statistically significant differences in Fos protein IR-labeling were 
observed in the heroin-trained-tested, heroin-trained-no-test or drug-naive groups (see 
Figure 20). 
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Prelimbic cortex. No statistically significant differences in Fos protein IR-labeling were 
observed in the heroin-trained-tested, heroin-trained-no-test or drug-naive groups (see 
Figure 21). 
Infralimbic cortex. No statistically significant differences in Fos protein IR-labeling were 
observed in the heroin-trained-tested, heroin-trained-no-test or drug-naive groups (see 
Figure 22). 
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Figure 17. Fos protein IR-labeling in the nucleus accumbens shell. Data shown are the 
mean (+SEM) counts of Fos protein IR cells in the food restricted (FDR) and Sated 
group, for the heroin-trained-tested, heroin-trained-no-test and drug-naive groups. On 
abstinence day 14, rats were immediately sacrificed following a 1 h test under extinction 
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Figure 18. Fos protein IR-labeling in the nucleus accumbens core. Data shown are the 
mean (+SEM) counts of Fos protein IR cells in the food restricted (FDR) and Sated 
group, for the heroin-trained-tested, heroin-trained-no-test and drug-naive groups. On 
abstinence day 14, rats were immediately sacrificed following a 1 h test under extinction 
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Figure 19. Fos protein IR-labeling in the basolateral amygdala. Data shown are the mean 
(+SEM) counts of Fos protein IR cells in the food restricted (FDR) and Sated group, for 
the heroin-trained-tested, heroin-trained-no-test and drug-naive groups. On abstinence 
day 14, rats were immediately sacrificed following a 1 h test under extinction conditions, 
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Figure 20. Fos protein IR-labeling in the central amygdala. Data shown are the mean 
(+SEM) counts of Fos protein IR cells in the food restricted (FDR) and Sated group, for 
the heroin-trained-tested, heroin-trained-no-test and drug-naive groups. On abstinence 
day 14, rats were immediately sacrificed following a 1 h test under extinction conditions, 
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Figure 21. Fos protein IR-labeling in the prelimbic cortex. Data shown are the mean 
(+SEM) counts of Fos protein IR cells in the food restricted (FDR) and Sated group, for 
the heroin-trained-tested, heroin-trained-no-test and drug-naive groups. On abstinence 
day 14, rats were immediately sacrificed following a 1 h test under extinction conditions, 
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Figure 22. Fos protein IR-labeling in the infralimbic cortex. Data shown are the mean 
(+SEM) counts of Fos protein IR cells in the food restricted (FDR) and Sated group, for 
the heroin-trained-tested, heroin-trained-no-test and drug-naive groups. On abstinence 
day 14, rats were immediately sacrificed following a 1 h test under extinction conditions, 
or at the same time a test would have occurred.
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Summary 
 As expected, a robust increase in heroin seeking was observed in food restricted, 
but not sated rats, when they were returned to the drug associated environment. Analysis 
of neuronal activation, as reflected by the expression of Fos protein, revealed a 
significant inhibition of Fos expression in the nucleus accumbens shell of the FDR 
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General Discussion 
 Recent work in our laboratory has demonstrated an augmentation of heroin 
seeking in abstinent, chronically food restricted rats (D’Cunha et al., 2012). Thus, as 
expected, a prolonged period of food restriction resulted in a robust increase in heroin 
seeking, compared to sated rats, across all experimental groups in the current studies. 
These findings are consistent with considerable evidence supporting a modulatory role 
for food restriction on drug-related behaviors in humans (Cheskin et al., 2005; Hall et al., 
1992; Krahn et al., 1992) and in laboratory animals, where food deficiency drastically 
influences drug taking and the reinforcing properties of abused drugs (Carr, 2007; Carroll 
& Meisch, 1984; Stuber, Evans, Higgins, Pu, & Figlewicz, 2002).   
 The goal of the experiments described in Chapter 1 was to investigate the role of 
the CRF and corticosterone stress systems in the augmentation of heroin seeking by 
prolonged food restriction in abstinent rats. Treatment with R121919, a selective CRF1-R 
antagonist, or α-helical CRF, a non-specific CRF-R antagonist, did not result in a 
statistically significant reduction in heroin seeking behavior. However, treatment with 
RU486, a glucocorticoid receptor antagonist, did not have an effect on heroin seeking. 
We therefore suggest that the acute stress response is not a critical factor in the 
augmentation of heroin seeking induced by prolonged food restriction. The experiments 
in Chapter 2 were therefore exploratory in nature and aimed at the identification of brain 
sites involved in this effect.  
 To that end, Fos protein immunoreactivity (Fos-IR) was used to measure neuronal 
activation in the BLA, CeA, NAcS and NAcC, il-PFC and pl-PFC. Interestingly, Fos-IR 
was statistically significantly attenuated in the NAcS of food restricted rats, compared to 
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the sated rats in the heroin-trained-tested group, while no other statistically significant 
effects were observed. 
 
The role of stress systems in chronic food-restriction-induced augmentation of heroin 
seeking in the rat 
 Despite previous evidence demonstrating that CRF-R antagonists attenuate food 
deprivation-induced reinstatement of extinguished heroin seeking (Shalev, Marinelli, 
Baumann, Piazza, & Shaham, 2003a), the experiments described in Chapter 1 suggest 
that these findings do not extend to chronic food restriction-induced augmentation of 
heroin seeking in abstinent rats. The observed lack of effect for CRF-R antagonists in 
chronically food restricted rats may be due to the use of different dietary regimens. As 
mentioned in the general introduction, chronic food restriction and acute food deprivation 
may differently affect metabolic systems and behavior. An additional reason for the 
different findings with acute and chronic food restriction might be the differences 
between the reinstatement procedure and our revised procedure. First, rats in the present 
study did not undergo a period of extinction, and as previously mentioned, extinction and 
abstinence can activate distinct neural circuits (Fuchs, Lasseter, Ramirez, & Xie, 2008a). 
Second, our study employed a prolonged period of mild stress (food restriction). 
Alterations in gene expression suggest distinct neural circuitry underly acute and chronic 
stress. For example, increased CRF1-R and c-fos mRNA in the PVN of the hypothalamus 
are observed following acute, but not chronic stress. In contrast, chronic stress results in 
lowered levels of CRF1-R and c-fos mRNA (Bonaz & Rivest, 1998). However, other 
reports have demonstrated the opposite result, where increased levels of CRF1-R mRNA 
  76 
were reported following chronic but not acute stress (Imaki, Nahan, Rivier, Sawchenko, 
& Vale, 1991). Notwithstanding these inconsistencies, there appear to be distinct 
adaptations in the CRF system following exposure to acute or chronic stress.  
 Additionally, it has been demonstrated that CRF can influence the long-term 
enhancement of synaptic transmission (long term potentiation, LTP) in the dentate gyrus 
of the hippocampus. For example, acute infusions of CRF in the hippocampus can result 
in long-lasting adaptations in the synaptic efficacy of hippocampal neurons, an effect 
which is abolished by CRF-R antagonist pre-treatment (Wang, Wayner, Chai, & Lee, 
1998). The hippocampus projects to the NAc and is strongly implicated in memory 
formation and the contribution of emotional memories to addiction (Nestler, 2005a). 
Chronic exposure to cocaine, opiates and nicotine has been shown to inhibit the birth of 
new neurons in the hippocampus (Eisch, 2000; 2002). Moreover, chronic exposure to 
cocaine can also stimulate dendritic growth in the NAc, which consequently allows for an 
enhanced influence on NAc neurons by afferent projections from surrounding regions 
such as the hippocampus (Nestler, 2005a). Nestler and colleagues (2001; 2005b) have 
suggested that cognitive impairments in drug addicted individuals may be driven by these 
long-lasting alterations in hippocampal neurons, and in turn in their influence on the 
reward circuitry. Therefore, the connecting circuitry between the hippocampus and other 
brain regions within the mesocorticolimbic DA circuitry suggests a pathway by which 
CRF can act to cause long lasting adaptations that influence drug seeking behavior.  
 In the present study, rats were exposed to a 14 day food restriction stress, which 
may have resulted in adaptations in critical neuronal circuits long before the test session. 
For example, greater DA tissue levels in the NAc, and reduced levels in the PFC, were 
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found 1 week following a 13 day exposure to CRF (Izzo, Sanna, & Koob, 2005). Thus, 
acute CRF-R antagonist treatment prior to testing may not have an important influence on 
the CRF-induced adaptations in the current procedure. Future studies should investigate 
the effects of chronic CRF-R antagonist treatment, over the food restriction period, in the 
augmentation of heroin seeking induced by chronic food restriction. A differential role 
for acute versus chronic treatment with CRF antagonists is suggested by the findings of 
Mallo and colleagues (2004) who reported a reduction in anxiety (as defined by increased 
exploration) in an elevated-zero-plus-maze test following chronic, but not acute treatment 
with a selective CRF1-R antagonist. 
 Null effects in the present study (Chapter 1; Experiment 1) may have been due to 
the choice of CRF-R antagonists. R121919 and α-helical CRF were used, the former a 
selective CRF1-R antagonist and the latter a non-selective CRF-R antagonist, with a high 
affinity for CRF1 and CRF2-Rs (Behan et al., 1996). As mentioned in the introduction of 
Chapter 1, CRF2-Rs may be involved in increased anxiety-like behaviors and drug self-
administration (Funk & Koob, 2007) however, their role in stress is not clear (Bale & 
Vale, 2004). For example, ethanol dependent rodents decrease ethanol self-administration 
in response to intra-CeA infusions of urocortin 3 (Ucn3), a highly selective CRF2-R 
agonist (Funk et al., 2007). In contrast, intra-CeA infusion of Ucn3 increased ethanol, but 
not water, self-administration in non-ethanol dependent rats (Funk & Koob, 2007). The 
authors further suggest that CRF1-R and CRF2-R may have opposing actions in the basal 
forebrain. Wang and colleagues (2007) have also demonstrated that CRF2, but not CRF1-
R blockade in the VTA can reduce elevated glutamate and DA concentrations and 
attenuate footshock stress-induced reinstatement of cocaine seeking (Wang et al., 2005).  
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 Taken together, these studies suggest that CRF2-Rs activation at particular brain 
areas might have a role in drug seeking, and therefore the results in the present study 
should be interpreted with caution as the CRF2-Rs were not specifically manipulated, and 
no site-specific injections were used. Nevertheless, the fact that blockade of both CRF1-R 
and CRF2-Rs using a non-specific antagonist did not affect drug seeking strongly 
suggests that acute activation of the CRF system is not involved in this phenomenon. 
 An interesting, albeit not statistically significant, trend for a dose dependent 
reduction in responding on the previously heroin paired (active) lever on the test day was 
observed in the α-helical CRF-treated sated group. Recently, CRF-R antagonism was 
shown to reduce cue-induced reinstatement of drug seeking (Moffett & Goeders, 2006), 
which could provide a possible explanation for the reduction of active lever responding 
observed in sated rats in the current experiments, following exposure to the drug-
associated environment and cues. However, a similar pattern was found for inactive lever 
responding in the food restricted and sated groups, suggesting that the reduced lever 
seeking in the α-helical CRF-treated rats was not due to changes in the motivational value 
of the drug-associated stimuli. Furthermore, administration of R121919 did not reduce 
active or inactive lever responding in the drug treated groups, further supporting a lack of 
motivational effects for CRF-R antagonists in the current procedure. It is possible that 
treatment with α-helical CRF resulted in an overall reduction of locomotor responding, 
which was obscured by the increased drug-seeking behavior in the food restricted rats; 
yet, we found no indication for such an effect in the previous studies conducted in our 
laboratory (Shalev et al., 2006). 
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 Since the treatment with α-helical CRF had no effect on drug seeking in the food 
restricted group, the administration of α-helical CRF was investigated under anxiety 
provoking conditions to ensure the efficacy of the drug. In this test, a reduction in 
anxiety, as assessed by a reduction in the latency to consume food and the number of 
approaches prior to food consumption, in food restricted rats that received α-helical CRF 
treatment was found. Rats that did not receive the drug treatment approached the food 
multiple times with no attempt at consumption and would instead continue to explore the 
environment. We interpreted this to be a sign of conflicting behavior resulting from 
elevated anxiety, as the rats were clearly hungry. 
 Given the apparent absence of a role for CRF (Chapter 1; Experiment 1) in 
protracted food restriction-induced augmentation of drug seeking, we investigated the 
role of corticosterone, the major stress-associated hormone (Chapter 1; Experiment 2). 
ACTH and the subsequent production of corticosterone can also be affected by 
mechanisms independent of CRF’s actions in the HPA axis (Tsigos & Chrousos, 2002). 
Previous research suggests an increase in plasma corticosterone concentrations as a result 
of reward and stress (including dietary restriction) presentations (Burgess et al., 1993; 
Goeders, 1997; Heiderstadt, McLaughlin, Wright, Walker, & Gomez-Sanchez, 2000; 
Merali, McIntosh, Kent, Michaud, & Anisman, 1998; Szechtman, Lambrou, Caggiula, & 
Redgate, 1974). These stress-induced elevations in corticosterone, however, are thought 
to have no role in stress-induced reinstatement of drug seeking (Erb et al., 1998; Shaham 
et al., 1997; Shalev, Marinelli, Baumann, Piazza, & Shaham, 2003a). It is relevant to note 
however, that the majority of these reports manipulated drug taking with acute stressors, 
and while stressors such as acute food deprivation can elevate plasma concentrations of 
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corticosterone, they do so at lower levels compared with other stressors such as cold or 
heat (Djordjević, Cvijić, & Davidović, 2003). Chronically food restricted rodents exhibit 
greater levels of corticosterone compared to controls (Carr, 1996). More so, the elevated 
concentrations observed following food restriction are positively associated with the 
proclivity to self-administer cocaine. Additionally, the removal of corticosterone via 
aderenalectomy can also decrease the heightened locomotor activity to a psychostimulant 
challenge in food restricted rats (Deroche et al., 1995; Piazza & Le Moal, 1996). 
 Thus, it was crucial to follow up Experiment 1 by investigating the role of 
corticosterone in our revised model. As we expected, acute treatment with a 
glucocorticoid antagonist, RU486, did not reduce increased heroin seeking in rats with a 
history of chronic food restriction. These results are consistent with past studies in the 
literature on stress- and reward-related behaviors. First, in CRF deficient mice, activity in 
an anxiety provoking situation (e.g., elevated plus maze) remains unaffected, in spite of a 
sufficiently blunted HPA axis response and lowered concentrations of corticosterone 
(Dunn & Swiergiel, 1999). Therefore, a heightened physical stress response may not 
always be necessary for the expression of stress-related behaviors. Second, Abrahamsen 
and colleagues (1996) suggested that in an LHSS procedure, the sensitization of 
rewarding efficacy of the stimulation by food restriction is unaltered following a 
treatment with a corticosterone synthesis inhibitor, or a feeding-induced decreases in 
plasma corticosterone (Abrahamsen, Berman, & Carr, 1995). The aforementioned studies 
argue against a modulatory role for corticosterone in rewarding behaviors. As Carr 
(2002) suggests, however, the most comprehensive test of corticosterone’s involvement 
in food restriction would be to maintain corticosterone concentrations in the food 
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restricted group at similar concentrations as those reported in the sated controls over the 
full period of restriction. With this recommendation in mind, we suggest that future 
studies investigate the long-term elevation of corticosterone by food restriction and 
whether this elevation may lead to adaptations that cannot be manipulated by the acute 
inhibition of corticosterone.  
 To ensure that RU486 successfully blocked corticosterone binding to its 
receptors, tail blood was collected immediately after the test session in the operant 
conditioning chambers. As expected, concentrations of corticosterone were statistically 
significantly greater in food restricted and sated rats after treatment with RU486 
compared to the vehicle pretreatment. Interestingly, the magnitude of increase in the food 
restricted group (~ 500%) was greater than that in the sated group (~ 74%) following 
RU486 treatment. We speculate that these differences in magnitude can be explained by a 
food restriction-induced elevation of corticosterone. One point of interest is that RU486 
is not selective to glucocorticoid receptors, but shows progesterone receptor antagonist 
properties as well. In fact, it possesses greater relative binding affinities (RBA) for 
progesterone (RBA: 530) compared to glucocorticoid (RBA: 300) receptors 
(Moguilewsky, 1985); this lack of receptor specificity however, is not relevant here as 
null effects were observed following administration of RU486 in our procedure. 
 Another interesting pattern in the current study (Chapter 1; Experiment 2) 
involves a non-statistically significant pattern of decreased active and inactive lever 
responses following RU486 treatment. This is in agreement with findings from previous 
studies that reported an attenuation of locomotor responding in cocaine treated rats after 
RU486 injections (Wu et al., 2008). These effects however, were observed using 3 mg/kg 
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and not in a 25 mg/kg dose (Wu et al., 2008), the latter of which is closer to the 30 mg/kg 
used in the present study. Additionally, a dose of 25 mg/kg of RU486 did not reduce 
wheel running after a fasting-induced increase in locomotor activity was observed 
(Challet, Lemaho, Robin, Malan, & Cherel, 1995). Thus, the literature has not provided 
any consistent reports on the effects of RU486 on locomotor activity. Future studies 
should investigate the removal of adrenal glands by means of adrenalectomy in 
combination with corticosterone replacement to elucidate the role of corticosterone or 
progesterone specifically. Removal of the adrenal glands is particularly important as it 
will avoid the receptor antagonist-induced augmentation of corticosterone levels 
observed in the present study, which may have unexpected effects on drug seeking 
behavior. This last point may be pertinent as the removal of adrenal glands has been 
effective in blocking stress-induced potentiation of conditioned place preference to 
morphine (Der-Avakian et al., 2005).  
 In conclusion, we suggest that the acute stress response has no role in the 
augmentation of heroin seeking by prolonged food restriction. There is evidence that the 
augmentation of drug seeking following food restriction can be modulated by non-stress 
related mechanisms that are triggered by the hunger state (Cabeza de Vaca & Carr, 1998), 
which provide alternate mechanisms of action that drive heroin seeking in our procedure. 
In agreement with this suggestion, recent evidence from our laboratory has reported that a 
2 or 24 h re-feeding period eliminated the augmentation of heroin seeking induced by 
food restriction after a period of abstinence (D’Cunha et al., 2012). The hunger state 
alone is not sufficient to drive drug seeking in our procedure, however, and requires a 
history of prolonged food restriction as well. Similar dietary manipulations have been 
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shown to alter hormonal and homeostatic mechanisms. For example, reductions in 
plasma and brain insulin concentrations represent an alternative mechanism by which 
chronic food restriction can regulate reward-related behaviors (Cabeza de Vaca & Carr, 
1998; Woods et al., 1985). There is evidence that chronically decreased plasma 
concentrations of insulin, in diabetic animals, results in reductions in DA transporter 
(DAT) mRNA in the VTA and substantia nigra (SN) (Figlewicz, Brot, McCall, & Szot, 
1996). In contrast, central injections of insulin increase expression of the DAT mRNA in 
the VTA and SN (Figlewicz, Szot, Chavez, Woods, & Veith, 1994). This suggests the 
involvement of insulin in the sensitization of the brains reward circuitry.  
 As well, two additional hormones, leptin and ghrelin, which are involved in 
energy balance and body weight regulation, have been linked to the modulation of drug 
and natural rewards through their effects on the mesocorticolimbic DA circuitry 
(Cummings, Naleid, & Figlewicz Lattemann, 2007). Infusions of ghrelin, an orexigenic 
gut hormone, can increase extracellular DA concentrations in the NAc (Jerlhag et al., 
2007), and cocaine-induced increases of extracellular DA in the NAc are attenuated by 
ghrelin receptor antagonism (Jerlhag, Egecioglu, Dickson, & Engel, 2010). In ghrelin 
knockout mice, alcohol-induced increases in NAc DA levels is suppressed (Jerlhag, 
Landgren, Egecioglu, Dickson, & Engel, 2011), while treatment with ghrelin receptor 
antagonists in alcohol dependent rats was shown to attenuate self-administration of 
ethanol (Landgren et al., 2011). Importantly, increased serum concentrations of ghrelin 
have been observed in response to cue-induced reinstatement of cocaine seeking (Tessari 
et al., 2007). Treatment with a ghrelin antagonist however, did not impair the food 
deprivation-induced reinstatement of heroin seeking, although central infusions of ghrelin 
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did increase the breakpoints on a progressive ratio schedule of heroin reinforcement 
(Maric, Sedki, Ronfard, Chafetz, & Shalev, 2011). It is critical to note, however, that the 
aforementioned study used acute food deprivation in a reinstatement of extinguished drug 
seeking procedure, which as mentioned above might involve different brain mechanisms 
than prolonged food restriction in abstinent rats. 
 Leptin, an anorexigenic hormone that is secreted by peripheral adipocytes, can 
regulate activity in the mesocorticolimbic circuitry (Cummings et al., 2007) through its 
actions on VTA DA neurons, and has been implicated in reward processes. Interestingly, 
leptin was shown to attenuate acute food deprivation-induced reinstatement of heroin 
seeking (Shalev, Yap, & Shaham, 2001b). However, this effect was not consistent across 
stress- (footshock) or heroin priming-induced reinstatement (Shalev et al., 2001b), 
suggesting that leptin’s effect was not mediated by DA or stress-related pathways.  
 The hormones described above may present alternative mechanisms by which the 
augmentation of heroin seeking following prolonged food restriction is achieved. 
 
The effects of chronic food restriction on Fos immunoreactivity in the nucleus accumbens 
in heroin seeking rats 
 In Chapter 2 we described a reduction of Fos protein-immunoreactivity (Fos-IR) 
in the NAcS for heroin-trained-tested rats who where subjected to a prolonged food 
restriction, compared to those with unrestricted access to food (sated). This is in contrast 
to the report that heightened Fos-IR levels are observed in the NAcS after repeated stress 
exposure (Nikulina, Covington, Ganschow, Hammer, & Miczek, 2004), and that transient 
inhibition of the NAcS using GABA agonists attenuates a footshock stress-induced 
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reinstatement of cocaine seeking (McFarland et al., 2004). Carr and colleagues (2000), 
however, reported increases in Fos-IR only in amphetamine challenged, but not saline 
control rats using a more severe regiment of food restriction.  
 The food restriction-induced inhibition of neuronal activation in the NAcS we 
report here is in agreement with recent findings indicating that the NAcS may play a 
bidirectional role in drug seeking, depending on DA and glutamatergic inputs. Thus, 
AMPA receptor (a glutamate receptor) activation in the il-PFC (which results in 
glutamate release in the NAcS) resulted in a suppressed cue-induced reinstatement of 
cocaine seeking. This effect was reversed by intra-NAcS infusions of DA, activation of 
VTA DA neurons (thereby increasing DA release in the NAc), or by AMPA receptor 
antagonists (LaLumiere, Smith, & Kalivas, 2012a). These findings suggest that the 
existence of high extracellular DA concentrations or impaired glutamatergic input to the 
NAcS is necessary for the expression of drug seeking. The authors further speculate that 
DA release in the NAcS might inhibit neuronal activation, resulting in the enhanced 
expression of drug seeking. It should be noted, however, that the aforementioned studies 
investigated drug seeking following psychostimulant, but not opiate drug use. 
Nevertheless, preliminary findings in our laboratory show an increase in extracellular DA 
in food restricted, abstinent rats with a history of heroin self-administration, during a test 
for drug seeking (D’Cunha, Hamel, Sedki, & Shalev, 2012).  
 Thus, in the present study, the reduction of Fos-IR in the NAcS of food restricted 
compared to sated rats in the heroin-trained-tested group may be the result of increased 
DA release following exposure to the drug-associated stimuli, resulting in the 
augmentation of drug seeking. A similar reduction in Fos-IR in the food restricted group 
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was not observed in the drug-naive or heroin-trained-no-test rats (that were not exposed 
to the drug environment). 
  Future studies should investigate this reduction in Fos-IR following non-
contingent exposure to heroin, and sucrose or saline self-administration. First, these 
studies can examine whether self-administration as compared to passive exposure to the 
drug is necessary for the decrease in NAcS Fos-IR. Second, they can clarify whether 
reduced activation in the NAcS is associated with exposure to drug-conditioned stimuli as 
compared to natural rewards-conditioned stimuli. Additionally, in the present procedure 
rats were exposed to contextual and discrete cues during the test session. As mentioned in 
Chapter 2, the NAcS is critical for context induced-drug seeking. Further studies should 
examine the particular contribution of the discrete and contextual cues. For example, the 
drug context could be extinguished during the prolonged food restriction prior to the test 
session, and Fos-IR analyzed as in the current study. 
 Previous reports have demonstrated elevated Fos-IR expression in the il-PFC 
following the context-induced reinstatement of heroin seeking. Furthermore, a reduction 
in context-induced reinstatement of heroin seeking is observed following transient 
inhibition of the il-PFC by GABA agonists (Bossert et al., 2011). Furthermore, an 
increase in Fos-IR was observed in the il-PFC cortex following a test for the renewal of 
extinguished cocaine seeking (Hamlin, Clemens, & McNally, 2008). We therefore 
expected a rise in Fos-IR in the il-PFC in food restricted rats compared to sated controls; 
however no increase in activation was observed. It is worth noting that in the above-
mentioned studies, drug seeking was extinguished prior to reinstatement tests. It is 
possible that the il-PFC is involved in the extinction of conditioned drug seeking and not 
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necessarily drug seeking itself. In the present study rats underwent a period of abstinence, 
but not extinction, which could explain the absence of changes in Fos-IR.  
 The absence of any distinct activation in the NAcC or pl-PFC between the food 
restricted and sated groups was unexpected, particularly because the pathway from the 
prelimbic cortex (pl-PFC) to the NAcC has been strongly implicated in the potentiation 
of drug-seeking behavior (LaLumiere & Kalivas, 2008; Peters, Kalivas, & Quirk, 2009). 
Increased output of extracellular glutamate is observed in the pathways from the pl-PFC 
to the NAcC during a cocaine-primed reinstatement (Baker et al., 2003). Moreover, 
increased extra-cellular levels of glutamate have been measured in the NAcC during 
footshock stress-induced reinstatement of cocaine seeking, and this increase was blocked 
by dorsal PFC inactivation (McFarland et al., 2004). We speculate that heightened 
neuronal activation in the NAcC may have occurred in the heroin-trained-tested, but no 
differences were observed as the food manipulation did not affect such activation, 
suggesting that the augmentation of drug seeking in the food restricted rats is not related 
to neuronal activation in the dorsal PFC. This idea is supported by the fact that no 
differences in Fos-IR between the drug-naive food restricted and sated groups were 
observed. Perhaps a comparison between the food restricted heroin-trained-tested group 
versus the food restricted heroin-trained-no-test or drug naive rats would have revealed 
increased activation during the drug seeking test. The purpose of the current study, 
however, was to elucidate the differences between food restricted and sated rats and 
therefore not all possible comparisons were performed, in an attempt to increase the 
power of the statistical analysis.  
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 The absence of differences in Fos-IR in the pl-PFC between the feeding 
conditions was particularly interesting, as acute food deprivation-induced reinstatement 
of heroin seeking resulted in an augmentation of Fos-IR in the pl-PFC (Shalev, Robarts, 
Shaham, & Morales, 2003b). However, rats in the aforementioned study were subjected 
to a period of extinction, and while the pl-PFC is integral to the modulation of drug 
seeking after extinction training, it is not necessary for the expression of drug seeking 
following a period of abstinence without extinction training (Fuchs et al., 2006). 
Furthermore, while there is evidence that supports greater Fos-IR levels in the pl-PFC 
after long-term abstinence from psychostimulant drugs (Ciccocioppo, Sanna, & Weiss, 
2001), there is no literature on the effects of prolonged food restriction.   
 As previously suggested in the introduction to Chapter 2, the amygdala is 
implicated in stress, drug reward, conditioned drug rewards and relapse. For example, 
lesions of the BLA, but not the NAc attenuated responding for a cocaine-paired 
conditioned stimulus (Grimm & See, 2000; Whitelaw et al., 1996). Moreover, stimulation 
of the BLA results in the reinstatement of cocaine and amphetamine seeking (Hayes et 
al., 2003; Taepavarapruk & Phillips, 2003; Vorel, Liu, Hayes, Spector, & Gardner, 2001). 
However, Fuchs and colleagues (2006; 2005) have demonstrated that the BLA is critical 
to the expression of the context-induced reinstatement of extinguished cocaine seeking 
but not to the augmentation of drug seeking following protracted abstinence. 
 Lastly, although exposure to a drug discriminative stimulus following abstinence 
from cocaine has been reported to increase Fos-IR in the BLA (Ciccocioppo et al., 2001), 
drug-cue-induced increases in neuronal activation would have been reflected in both the 
food restricted and sated groups, and apparently it is not affected by feeding condition. 
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This conclusion is supported by the lack of differences in Fos-IR between FDR and sated 
rats in the drug-naive and heroin-trained-no-test-groups. 
 No effects in Fos-IR where observed in CeA. This region was chosen as it is a 
critical component of the brains stress circuit (Kalivas & McFarland, 2003), and is 
involved in expression of drug seeking behavior in response to stress (Kalivas & Volkow, 
2005). Our data, however, are consistent with previous findings indicating no distinct 
patterns of Fos-IR in the CeA in an acute food deprivation-induced reinstatement of 
heroin seeking when compared to sated controls (Shalev, Robarts, Shaham, & Morales, 
2003b). Finally, since the findings described in Chapter 1 suggest that the stress response 
is not involved in food restriction-induced augmentation of drug seeking in our 
procedure, the lack of differences in CeA activation is not an unexpected result. 
 One limitation of the Chapter 2 experimental procedure is the difficulties in the 
use of Fos-IR labeling, which may result in inconsistencies. For example, c-Fos has a 
generally low activation threshold in certain brain areas and therefore neuronal 
deactivation (inhibition) is difficult to identify. A second limitation was the low number 
of rats in the heroin-trained-no-test group (n’s: FDR - 3, Sated - 5). These small sample 
sizes resulted in a large degree of variability within each group and a reduced power. 
Also, the method in which animals were prepared for perfusion may have led to changes 
in Fos protein expression. As previously mentioned, Euthenol was used to anesthetize the 
rats prior to perfusion. In some cases the animal took almost 40 minutes to be fully 
anesthetized. This time was undoubtedly very stressful for the rat and may have 
inadvertently led to increased Fos-IR expression in some regions. Finally, time of 
sacrifice following testing used here might not have been optimal. Rats were sacrificed 
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immediately following a 60 min test session. Others have often used a 90-120 min 
session or a 60 min session followed by a 30 min time out prior to the sacrifice (D'Este, 
Scontrini, Casini, Pontieri, & Renda, 2002; Darcel et al., 2005; Dayas, Liu, Simms, & 
Weiss, 2007; Shalev, Robarts, Shaham, & Morales, 2003b). It is therefore possible that 
we missed the peak of the Fos activation, resulting in less than ideal conditions to identify 
subtle differences between groups.  
 Analysis of all the brain regions involved in drug reward, stress and drug seeking 
is beyond the scope of this thesis and therefore we briefly mention other brain sites that 
may provide insight on the mechanisms that underlie the augmentation of heroin seeking 
in our procedure. These brain sites present viable targets for future analysis due to their 
critical role in the expression of conditioned drug rewards following abstinence. Kalivas 
and colleagues (2005) have indicated that the ventral palladium is crucial as it contributes 
to a “final common pathway” which drives drug-seeking behavior. The same group has 
also proposed a role for the substantia nigra, dorsal striatum and somatosensory cortex in 
the expression of drug seeking following abstinence (Kalivas, 2008). Furthermore, the 
orbitofrontal cortex (OFC) is also implicated in conditioned drug rewards following 
protracted abstinence, as increased Fos-IR levels are found in this region following tests 
for cocaine seeking in abstinent rats (Zavala, Biswas, Harlan, & Neisewander, 2007). 
Finally, studies have suggested that elevated Fos-IR levels in the VTA are observed 
during a cue-induced test for cocaine seeking, following prolonged abstinence (Kufahl et 
al., 2009). Together, these brain sites present viable targets for future analysis due to their 
critical role in the expression of conditioned drug rewards following abstinence. 
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Conclusion 
 In conclusion, we present here a set of experiments (Chapter 1) which indicate 
that pathways involved in the acute response to stress are not critical for the expression of 
augmented drug seeking in abstinent, food restricted rats. The long-term manipulation of 
CRF and the corticosterone stress systems, from the inception of the food restriction 
period to the test session, may elucidate the role of the these hormones in our procedure. 
 Data from Chapter 2 demonstrated that food restriction in heroin-trained-tested 
rats decreased Fos-IR levels in the NAcS, when compared to sated controls. The finding 
that food restriction selectively decreased Fos-IR in the heroin-trained-tested but not the 
heroin-trained-no-test or drug-naive groups suggests that this effect is specific to drug 
seeking and not a general response to food restriction. Finally, our finding is in agreement 
with a recently suggested model that postulates that drug seeking is driven by an 
inhibition of neuronal activation in the NAcS that can result from enhanced DA release 
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Appendix A: Project Timeline 
 
 
Figure A1. Timeline of experimental procedure. The procedure consists of three phases: 
animals are first trained to self-administer a drug in the presence of a cue/tone complex 
(training phase), then moved to a different context and undergo a one day, drug washout 
period, followed by a prolonged period of food restriction (FDR) or unlimited access to 
food (abstinence phase) and finally returned to the self-administration environment for a 
drug-seeking test in the presence of drug-paired cues under extinction conditions (test 
phase). 
 
 
